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ABSTRACT 
The success of fracture healing relies on coordinated overlapping cellular and molecular 
events. 10-15% of cases worldwide result in delayed healing, non-union or pseudarthrosis. 
Therefore, analysis of molecular and cellular healing events is important to discover new 
therapeutic attempts in clinical research. Besides, engineering a blueprint of differential 
regulation throughout physiological healing is essential to specify phase-specific markers. 
Such undercarriage will pinpoint irregular gene expression, whether chronological, 
temporal or functional. This study analyzed the healing progression of standard closed 
femoral fracture in C57BL/6N (age = 8 weeks) wild type male mice model. Fracture callus 
was assessed at days 3, 7, 10, 14, 21, and 28 post fracture by microarray and histological 
analysis. Results revealed increased bone mineralization with healing progression and 
bony bridging was seen by day 28. In-depth analysis of bone matrix mineralization 
showed changes in collagen orientation and osteocytes morphology with healing 
progression. Differential expression analysis followed by gene ontology associated genes 
with angiogenesis, ossification, extracellular matrix regulation, immune response, 
mitochondrial, and ribosomal activity. However, the overlapping genes between 
consecutive time points were not addressed before. This thesis compared consecutive time 
points to study the overlapping genes in correlation to healing events. In accordance to 
previous reports, this thesis showed the importance of angiogenesis, ossification, immune 
response, and extracellular matrix regulation leading to successful healing. However, the 
individual role of mitochondrial and ribosomal genes in bone regeneration remain 
unknown. Differential analysis in this study showed drastic downregulation among the 
mitochondrial and ribosomal genes during the early phase of healing. Further, histological 
evaluation of mitochondrial marker (GPX1) and ribosomal marker (UBB) showed patches 
of positive stain in osteocytes and blood vessels vicinity during the course of healing. In 
summary, this study shows the importance of mitochondrial and ribosomal genes besides 
angiogenesis, ossification, extracellular matrix, and immune response to reach the 
successful bony consolidation. Moreover, this mouse fracture model can be used as a 
template to identify specific molecular mechanism of fracture healing.  
.
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ZUSAMMENFASSUNG 
Eine erfolgreiche Frakturheilung ist das Ergebnis ineinandergreifender zellulärer und 
molekularer Ereignisse. Weltweit zeigen 10-15% aller Frakturen eine verzögerte Heilung, 
„Non-Union“ oder Pseudarthrose. Das detailliert Verständnis der Frakturheilung ist essentiell 
für die Wahl der Behandlungsmethode. Daher ist die Analyse der molekularen und zellulären 
Heilungsprozesse wichtig, um neue therapeutische und klinisch relevante Ansätze zu 
entdecken. Anhand eines Modelles zur physiologischen Knochenheilung können für die 
Heilungsphasen spezifische Marker identifiziert werden und chronologische oder funktionelle 
Abweichungen bei pathologischer Knochenheilung präzise aufgezeigt werden. In dieser Studie 
wurde der Heilungsprozess an einer geschlossenen Femurfraktur in einem C57BL/6N 
männlichem Wildtyp Mausmodell (Alter = 8 Wochen) untersucht. Hierbei wurde der 
Frakturkallus an den Tagen 3, 7, 10, 14, 21 und 28 mittels Mikroarray und histologischer 
Analysen untersucht. Hierbei zeigte sich an Tag 28 eine gesteigerte Knochenmineralisation 
mit fortschreitender Heilung und Verknöcherung des Kallus. Im Verlauf des 
Heilungsprozesses zeigten sich Veränderungen in der Kollagenfaserorientierung der 
Knochenmatrix und der Osteozytenmorphologie. Durch differentielle Genexpressionsanalysen 
konnten aktive Gene der Angiogenese, Ossifikation, extrazellulären Matrix, des 
Immunsystems sowie der mitochondrialen und ribosomalen Aktivität identifiziert und den 
Heilungsphasen zugeordnet werden. Eine derartige Studie mit aufeinander folgenden 
Zeitpunkten ist bisher einzigartig und zeigt zwischen den Zeitpunkten überlappende 
Genaktivitäten in den einzelnen Phasen der Frakturheilung. In Übereinstimmung mit 
vorangegangenen Studien zeigte sich hier die Bedeutung der Angiogenese, Ossifikation, 
extrazellulären Matrix und des Immunsystems für eine erfolgreiche Frakturheilung. Dennoch 
ist die Rolle der mitochondrialen und ribosomalen Gene bei der Frakturheilung bisher 
ungeklärt. In dieser Studie zeigte sich in der frühen Phase der Frakturheilung eine deutliche 
Herabregulation der mitochondrialen und ribosomalen Genaktivität. Zusätzlich zeigten sich 
bei den histologischen Analysen in den Osteozyten und den Blutgefäßen positive Areale für 
den mitochondrialen Marker (GPX1) sowie den ribosomalen Marker (UBB). Diese Studie 
belegt die Bedeutung von mitochondrialen und ribosomalen Genen zusätzlich zu der 
Angiogenese, Ossifikation, extrazellulären Matrix und dem Immunsystem an der 
erfolgreichen, knöchernen Konsolidierung bei der Frakturheilung. Darüber hinaus kann dieses 
Fraktur-/Mausmodell als Vorlage für die Identifizierung molekularer Mechanismen der 
Frakturheilung dienen.  
III 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my parents 
 
 
 
 
 
 
 
 
 
 
 
IV 
 
TABLE OF CONTENTS  
 
ABSTRACT --------------------------------------------------------------------------------------------------- I 
ZUSAMMENFASSUNG ----------------------------------------------------------------------------------- II 
TABLE OF CONTENTS --------------------------------------------------------------------------------- IV 
1. INTRODUCTION -------------------------------------------------------------------------------------- 1 
1.1 Structure of Bone ----------------------------------------------------------------------------------- 2 
1.2 Cellular Components of Bone -------------------------------------------------------------------- 3 
1.2.1 Osteoblasts -------------------------------------------------------------------------------------- 4 
1.2.2 Osteocytes -------------------------------------------------------------------------------------- 5 
1.2.3 Osteoclasts -------------------------------------------------------------------------------------- 5 
1.2.4 Bone lining cells ------------------------------------------------------------------------------- 6 
1.3 Fracture Healing ------------------------------------------------------------------------------------ 7 
1.3.1 Inflammatory phase --------------------------------------------------------------------------- 7 
1.3.2 Reparative phase ------------------------------------------------------------------------------- 7 
1.3.3 Remodeling phase ----------------------------------------------------------------------------- 8 
2. OBJECTIVES OF THIS STUDY ----------------------------------------------------------------- 10 
3. MATERIALS AND METHODS ------------------------------------------------------------------ 11 
3.1 Experimental Design ------------------------------------------------------------------------------ 11 
3.2 Animal Ethical Declaration ---------------------------------------------------------------------- 12 
3.3 Sample Preparation for Histological Evaluation ---------------------------------------------- 12 
3.4 Histological Staining ------------------------------------------------------------------------------ 12 
3.4.1 Sirius Red Stain ------------------------------------------------------------------------------- 12 
3.4.2 Trichrome Masson Goldner Stain ---------------------------------------------------------- 13 
3.4.3 Silver Nitrate Stain --------------------------------------------------------------------------- 13 
3.5 Immunohistochemical Staining ------------------------------------------------------------------ 13 
V 
 
3.5.1 Alpha Smooth Muscle Actin (ASMA) ---------------------------------------------------- 13 
3.5.2 Matrix Extracellular Phosphoglycoprotein (MEPE) ------------------------------------ 13 
3.5.3 Extracellular Signal Regulated Kinase (ERK) ------------------------------------------- 13 
3.5.4 Glutathione Peroxidase 1 (GPX1) ---------------------------------------------------------- 14 
3.5.5 Ubiquitin (UBB) ------------------------------------------------------------------------------ 14 
3.6 Image Acquisition and Histomorphometry ---------------------------------------------------- 14 
3.7 Quantification of Collagen Fibers --------------------------------------------------------------- 15 
3.8 Statistical Analysis -------------------------------------------------------------------------------- 15 
3.9 RNA Preparation and Microarray Hybridization --------------------------------------------- 16 
3.10 Data Normalization and Filtering Criteria ---------------------------------------------------- 16 
3.11 Clustering of Differentially Expressed Genes ----------------------------------------------- 17 
3.12 Functional Annotation of Differentially Expressed Genes --------------------------------- 17 
4. RESULTS----------------------------------------------------------------------------------------------- 18 
4.1 Comparison of FC cut-offs resulted in no variation in DEG pattern ----------------------- 18 
4.2 Overlapping genes between two consecutive time points: hallmark either by 
mitochondrial activity or by ECM regulation ------------------------------------------------------ 20 
4.3 Hierarchical clustering of genes based on expression pattern across time points 
generated ten distinct clusters ------------------------------------------------------------------------ 23 
4.4 D3 and D7 marked the active phase of differentially expressed angiogenesis genes ---- 26 
4.5 Evaluation of ASMA activity during fracture healing showed higher positive signal 
at D7 ----------------------------------------------------------------------------------------------------- 28 
4.6 D10 and D14 marked the active time points with differentially expressed ossification 
genes ----------------------------------------------------------------------------------------------------- 29 
4.7 Trichrome Masson Goldner depicted changes in bone mineralization with 
progression of fracture healing process ------------------------------------------------------------- 32 
4.8 D10 marked the active time point related to differentially expressed ECM genes ------ 34 
4.9 Changes in collagen fibers arrangement with progression of healing --------------------- 37 
4.10 Quantitative evaluation of osteocytes using silver nitrate stain showed lower count 
at D28 ---------------------------------------------------------------------------------------------------- 40 
VI 
 
4.11 Evaluation of MEPE and ERK during fracture healing showed negative correlation 
across time points -------------------------------------------------------------------------------------- 42 
4.12 High number of differentially expressed genes related to mitochondrial activity 
were present only at D3 and D7 ---------------------------------------------------------------------- 44 
4.13 Evaluation of GPX1 immunohistochemistry showed higher positive signal at D28 --- 48 
4.14 High number of differentially expressed genes related to ribosomal activity were 
present only at D3 and D7 ---------------------------------------------------------------------------- 50 
4.15 Evaluation of UBB immunohistochemistry showed higher positive signal at D7 ------ 53 
4.16 High number of differentially expressed genes related to immune response were 
present only at D10 ------------------------------------------------------------------------------------ 55 
5. DISCUSSION ------------------------------------------------------------------------------------------ 58 
5.1 Fold change cut-off and data interpretation ---------------------------------------------------- 59 
5.2 Fracture healing: series of overlapping events ------------------------------------------------ 60 
5.3 Hierarchical clustering method ------------------------------------------------------------------ 61 
5.4 Angiogenesis --------------------------------------------------------------------------------------- 62 
5.5 Ossification ----------------------------------------------------------------------------------------- 65 
5.6 Extracellular matrix ------------------------------------------------------------------------------- 66 
5.6.1 Osteocytes and ECM markers -------------------------------------------------------------- 68 
5.7 Mitochondrial activity ---------------------------------------------------------------------------- 69 
5.8 Ribosomal activity --------------------------------------------------------------------------------- 71 
5.9 Immune response ---------------------------------------------------------------------------------- 72 
6. CONCLUSION ---------------------------------------------------------------------------------------- 75 
7. IMPLICATIONS AND FUTURE DIRECTION ----------------------------------------------- 76 
APPENDICES----------------------------------------------------------------------------------------------- 77 
Preparation of samples for paraffin embedding --------------------------------------------------- 77 
Sirius Red Staining------------------------------------------------------------------------------------- 78 
Trichrome Masson Goldner Stain ------------------------------------------------------------------- 79 
Silver Nitrate Staining --------------------------------------------------------------------------------- 80 
VII 
 
Immunohistochemical Staining ---------------------------------------------------------------------- 81 
Histomorphometry using ImageJ (version 1.51) -------------------------------------------------- 84 
RNA isolation and Quality Control------------------------------------------------------------------ 85 
Quality assessment of Beadchip array using R ---------------------------------------------------- 86 
Hierarchical clustering of DEG using R ------------------------------------------------------------ 87 
Functional annotation using NCBI-DAVID (version 6.7) --------------------------------------- 88 
ABBREVIATIONS LIST --------------------------------------------------------------------------------- 91 
ACKNOWLEDGMENTS -------------------------------------------------------------------------------- 95 
THESIS DECLARATION ------------------------------------------------------------------------------- 96 
REFERENCES---------------------------------------------------------------------------------------------- 97 
 
 
 
1 
 
1. INTRODUCTION 
Fracture healing is a well-orchestrated series of biological events involving cellular 
recruitment, growth, and differentiation [1]. Fracture healing involves overlapping phases 
that begins with inflammation, advances to endochondral ossification, and ends with a 
remodeling phase. The interdependent healing events requires an interplay between 
different cell types and regulatory factors. Any dysregulation at cellular or molecular level 
during fracture healing results in delayed healing or non-union [2]. Developing new 
strategies to heal bone fractures continues to evolve with increasing knowledge of 
underlying molecular mechanism. Further, interdisciplinary research in recent years 
enabled to identify multiple signaling molecules involved in fracture healing.  
Transcriptomics is one of the most used technique to examine the underlying molecular 
mechanism of diseases. Microarray technology was previously used to exploit the 
temporal and spatial changes during fracture healing in a mouse model [3-5]. Nakzawa T 
et al. 2004 reported that differentially expressed genes present in the early phase of healing 
are important for periosteal callus formation [3]. Khan SN et al. 2008 reported the 
importance of leptin and its receptor in bone mineralization [4]. Bais M et al. 2009 showed 
the presence of common genes and signaling pathways shared between fracture healing 
and embryonic stem cells [5]. The information gained so far with transcriptomics has 
advanced the understanding of fracture healing. However, a deep understanding of 
overlapping healing events in successful fracture healing is still required. Therefore, 
fracture healing studies in wild type animal models are important for understanding the 
underlying cellular and molecular interactions.  
This experimental study hypothesized that differentially expressed genes overlapping 
between two successive time points can elucidate temporal alteration in molecular 
regulation during the healing. The study also hypothesized that ribosomal and 
mitochondrial genes are upregulated in the early phase of healing rather than the late 
phase. To test these hypothesis, a closed femoral fracture model of an eight-week-old wild 
type male mice was used. The animals were sacrificed at 3, 7, 10, 14, 21, and 28 days 
post-fracture and 0-day served as control. Whole genome transcriptomics and histological 
analysis were carried out to infer molecular and cellular changes. The study aims to 
examine the differentially expressed genes involved in angiogenesis, ossification, 
extracellular matrix regulation, immune response, mitochondrial, and ribosomal activity.  
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This study inferred multifunctional role of candidate genes in progressing fracture healing. 
Further, this thesis provided the first evidence -to my knowledge- of overlapping genes 
across consecutive time points of healing. Differential gene expression followed by gene 
ontology revealed significant downregulation of mitochondrial and ribosomal genes during 
successful healing. Immunohistochemical finding suggests a cross talk between ERK and 
MEPE, which reflected on regulatory role of extracellular matrix in healing. Further, 
morphological changes of osteocytes and collagen fiber arrangement with healing 
progression seen in this study reflected on bone mineralization and bone quality. The 
collective data from microarray analysis and histology provides a better understanding of 
fracture healing. 
1.1 Structure of Bone 
The skeletal system forms a solid framework that supports and protects the body’s organs 
and anchors the skeletal muscle. Bone is a dynamic connective tissue whose structure and 
composition reflects a balance between mechanical integrity and homeostasis [6].  
The mechanical properties of bone relies on its complex hierarchical structure [7]. Bone is 
divided into cortical (or compact) and trabecular (or cancellous) bone at macroscopic level 
[8]. Bone consists of dense outer layer of cortical bone with a porous interior of trabecular 
bone (Figure 1). The microstructure of cortical bone is composed of regular and 
cylindrical shaped lamellae. In contrast, the microstructure of trabecular bone is comprised 
of irregular and sinuous convolutions of lamellae [8].  
A long bone typically remains in the process of ossification for many years. The 
ossification of long bone goes through three parts distinctly: the epiphysis, metaphysis, 
and diaphysis [6]. The epiphysis refers to the either end of long bone separated from the 
rest of bone by a layer of growth plate cartilage. The metaphysis refers to the regions of 
transition from wider epiphysis to slender diaphysis (Figure 1). The ossification of 
diaphysis takes place before epiphysis by means of primary and secondary ossification 
centers [9].  
Inner and outer membrane surface of bone plays important role in bone modeling & 
remodeling, and fracture healing [10]. The outermost layer of bone composes of 
periosteum (Figure 1), which is responsible for appositional bone growth, partial blood 
supply to bone, and bone healing. Periosteum consists of an outer fibrous layer that 
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provides structural support and an inner cambium layer which is rich with osteoprogenitor 
cells (Figure 1). The inner layer of bone comprises of endosteum which arises from 
periosteum. Endosteum composes of a thin membrane and bone cells like osteoblasts and 
osteoclasts are present in endosteum [11]. 
Bone is mainly made of the extracellular matrix (ECM), which consists of vast variety of 
organic and inorganic constituents. The organic phase is composed of collagenous and 
inorganic phase is composed of non-collagenous proteins. ECM molecules control cell 
behavior and provides template for cell attachment and survival [12].  
 
Figure 1: An outline of the anatomical structure of bone. Cortical bone makes up to 80% 
of bones weight and trabecular bone makes up to 20% of bones weight. The periosteum 
forms the outer layer of bone and the endosteum lines the medullary cavity. (Modified 
from [13], BV: Blood vessels, LV: Lymphatic vessels). 
Type I collagen is the most rich collagenous protein present in bone tissue. Besides, 
collagen affects the structural characteristics and controls the distribution of apatite [14]. 
The main components of non-collagenous protein in ECM are Bone sialoproteins (BSP), 
osteopontin (OPN), osteonectin (ONC), and osteocalcin (OCN).  
1.2 Cellular Components of Bone 
Bone homeostasis is maintained by chemical, biological, and mechanical signaling 
molecules [15]. Three main cell types associated with bone homeostasis are osteoblasts, 
osteoclasts, and osteocytes. These cells are ordered into two lineages: the osteoblasts 
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lineage which represents the bone formation and the osteoclast lineage which represents 
bone resorption. Osteoblast lineage consists of chondrocytes, pre-osteoblasts, osteocytes, 
and bone lining cells that originate from mesenchymal stem cells [16]. Osteoclast lineage 
consists of macrophages, osteoclasts, and other multinucleated cells that originate from 
hematopoietic stem cells [17]. The balance between bone formation and bone resorption is 
important to preserve integrity of bone (Figure 2). Imbalanced bone formation and 
resorption result in systemic skeletal diseases like osteomalacia and osteoporosis [18]. 
Bone remodeling occurs with the coordinated activity of osteoblasts, osteoclasts, 
osteocytes, and bone lining cells that form the basic multicellular unit (BMU) [19, 20]. 
1.2.1 Osteoblasts  
Osteoblasts preserve skeletal architecture by deposition of bone matrix and osteoclasts 
regulation [21]. Osteoblasts migrate from bone marrow to bone surface where bone matrix 
deposition takes place in bone formation (Figure 2). Proliferation and differentiation of 
osteoblasts is carried out by cross talk of different signaling pathways. Transforming 
growth factor – beta (TGF-β) promotes osteoblast differentiation through Extracellular 
signal-regulated kinases (ERK), Wnt, and Bone Morphogenetic Protein (BMP) signaling 
[22]. ERK is a part of Mitogen Activated Protein Kinases (MAPK) signaling that also 
promotes osteoblasts adhesion to the bone matrix proteins like type I collagen beside 
osteoblast proliferation [23]. Disruption among signaling molecules leads to multiple 
diseases like tumor metastasis, osteoarthritis, neurodegenerative diseases, osteoporosis 
[24-28].  
Cell growth and proliferation needs the fundamental mitochondrial biogenesis for energy 
production and ribosomal biogenesis for protein production. Mitochondrial biogenesis is 
orchestrated by the transcriptional regulatory circuits between mitochondrial DNA and 
genes encoded by nucleus [29]. Wnt signaling increases mitochondrial biogenesis, which 
in turn, contributes to increased osteoblast differentiation [30]. Cellular metabolism results 
in reactive oxygen species (ROS) production, which contribute to cellular damage and 
apoptosis [31]. In such situations, antioxidant enzyme like Glutathione peroxidase 1 
(Gpx1) provides protection against oxidative stress to cells by keeping homeostasis [32]. 
Ribosome biogenesis controls growth, cell division rate, and cell survival [33]. Ubiquitin 
proteasome complex is one of the major part of ribosome biogenesis [34]. Runt related 
transcription factor 2 (Runx2) is the first transcription factor required to control osteoblast 
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lineage [35]. The main regulator of osteoblast differentiation i.e. Runx2 suppress 
ribosomal RNA (rRNA) gene transcription [36]. The inverse relation between rRNA and 
Runx2 provides a strong mechanistic link between ribosome biogenesis and osteogenesis 
[37]. Further, ubiquitin mediated protein degradation negatively regulate osteoblast 
migration and differentiation [38].  
1.2.2 Osteocytes 
Osteocytes compose 90-95% of total bone cells and are the most abundant & long-lived 
cells [39]. Osteocytes communicate with each other by a meshwork of cell processes that 
run through canaliculi set in bone matrix [40] (Figure 2). Further, osteocytes act as an 
orchestrator of bone remodeling through regulation of both osteoclasts and osteoblasts 
[41]. Osteocytes express selective markers like Dentin Matrix Protein 1 (DMP1), Matrix 
Extracellular Phosphoglycoprotein (MEPE), and Sclerostin (SOST) with an important role 
in bone formation, homeostasis, and pathology [42]. Dysregulation in osteocyte specific 
markers like MEPE or SOST results in severity like multiple myeloma [43] and dentin 
structural diseases [44]. 
1.2.3 Osteoclasts 
Osteoclasts are multinucleated cells formed by the fusion of mononuclear progenitors of 
the monocyte/macrophage family [45]. Osteoclast activity involves cell polarization to 
form resorptive machinery characterized by attaching bone matrix and forming ruffled 
border [46].  
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Figure 2: Overview of cellular events in basic multicellular unit. Bone homeostasis is 
preserved by a balanced osteoblast and osteoclast activity. Osteocytes acts as mechano-
sensors and provide support under stress condition. Bone lining cells are the old 
osteoblasts that make passage for mineral exchange (Adapted from [47]). 
The ruffled border transport enzymes and minerals into resorption cavity to degrade bone 
matrix proteins. The presence of ruffled border points to the active sites of osteoclasts 
mediated resorption. Differentiation of osteoclasts is regulated by Macrophage colony-
stimulating factor (M-CSF), Receptor Activator of Nuclear Factor Kappa B Ligand 
(RANKL), and Osteoprotegerin (OPG) [45]. RANKL is also expressed in abundance by 
T-lymphocytes. RANKL promotes osteoclastogenesis while OPG inhibits 
osteoclastogenesis (Figure 2). The balance between RANKL and OPG governs the 
quantity of bone resorbed [48]. Dysregulation in osteoclast activity leads to autoimmune 
disease like rheumatoid arthritis [49] and systemic skeletal disease like osteoporosis [50]. 
1.2.4 Bone lining cells 
Bone lining cells cover inactive bone surfaces where neither bone resorption nor bone 
formation can take place [51]. Bone lining cells enter the lacuna and clean the leftover 
collagen fibers with the help of Matrix Metalloproteinases (MMPs) after withdrawing 
osteoclasts from resorption pit [52]. Therefore, bone lining cells are important for balanced 
bone remodeling (Figure 2). 
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1.3 Fracture Healing 
Fracture repair is a complex process involving timed cellular recruitment, gene expression, 
and synthesis of compounds that regenerate native tissue to restore the mechanical 
integrity [53]. Many factors like fracture location, degree of stability, infection, patient’s 
characteristics, and premedication are associated with the success of fracture healing [2]. 
10-15% of cases result in delayed or non-union that need higher treatment costs [2]. 
Understanding fracture healing in a physiological condition is important step in developing 
therapeutics. 
Fracture healing is represented by a series of overlapping healing events that recaptulate 
stages of embryonic development [54]. The fracture healing has five main healing events, 
which are discussed below (Figure 3). 
1.3.1 Inflammatory phase 
Injury disrupts the blood vessels and surrounding soft tissue along with bone matrix. This 
leads to bleeding, hypoxic condition, and hematoma formation which triggers the early 
inflammatory response [55]. The onset of inflammation triggers migrating cytokines and 
growth factors at the site of injury to set up vascularization and preserve bone homeostasis 
[56]. T-lymphocytes and macrophage/monocytes act as initiating cell types in healing [57]. 
Pro-inflammatory cytokines like Interleukin 1 (IL-1), IL-6, tumor necrosis factor (TNF) 
are among the early released cells during inflammatory phase [58] (Figure 3). 
Lymphocytes migrate into the fracture callus after macrophage recruitment and begin the 
cell differentiation with adaptive immune response [59]. The timely termination of 
inflammation and early onset of revascularization process are independent and essential 
for a regenerative healing process [60]. However, systemic inflammation seen in patients 
with rheumatoid arthritis, diabetes mellitus, multiple trauma can increase fracture healing 
time or cause non-union [61]. 
1.3.2 Reparative phase 
Reparative phase overlaps with the inflammatory phase and contribute in blood vessel 
development. The hematoma formed during injury recruits mesenchymal stem cells that 
differentiate into chondrocytes to induce callus formation (Figure 3). Soft callus formation 
gives stability to fracture [62]. The peak of soft callus formation occurs 7-9 days post-
8 
 
trauma [2]. Chondrocytes multiply to become hypertrophic and calcify the ECM. The soft 
callus becomes mechanically rigid as the hard callus formation progresses and calcified 
cartilage get replaced by woven bone [63]. Fracture heals by two different mechanism: 
direct and indirect healing. Indirect healing occurs without stable condition while direct 
healing takes place in the presence of rigidly stable condition [64]. Direct healing involves 
intramembranous ossification. While, indirect healing involves endochondral and 
intramembranous ossification [63]: 
1. Endochondral ossification is characterized by the differentiation of mesenchymal stem 
cells into chondrocytes, which forms cartilaginous matrix and later get replaced by bone 
(Figure 3). Soft callus formation gives a stability to fracture. As the cartilage mineralizes, 
blood vessels invasion mediates an influx of osteoprogenitor cells that produce a central 
hard callus on top of mineralized cartilage matrixes and an influx of osteoclasts that resorb 
the calcified cartilage. As a result, the bony callus matures and undergoes remodeling with 
time, finally allowing bone to regain its original architecture and role [65] (Figure 3). 
While occasionally, problem in transition of cartilage to bone occurs and results in severe 
condition of osteoarthritis [66].  
2. Intramembranous ossification is characterized by direct differentiation of mesenchymal 
stem cells into osteoblasts. Intramembranous ossification occurs near to proximal and 
distal end to form hard callus [67]. While sometimes, progressive osseous heteroplasia 
occurs because of predominance of intramembranous ossification [68]. Further, skeletal 
dysplasia in osteogenesis imperfecta type II patients occur because of disorder in 
intramembranous and endochondral ossification [69]. 
1.3.3 Remodeling phase 
The woven bone transforms to lamellar bone during remodeling phase of healing. Bone 
remodeling is tightly regulated by osteoclast and osteoblast (Figure 3). The process of 
remodeling advances in tunnels with osteoclast forming “cutting cones” that remove the 
old and make way for osteoblasts to form new bone [70]. The balanced activity of 
osteoclasts and osteoblasts results in gradual increase of bone density and improved 
weight bearing quality [71]. While, imbalanced osteoclast and osteoblast activity results in 
systemic skeletal disease like osteoporosis [72]. 
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Figure 3: Interdependent stages of fracture healing in a wild type mouse model. 
Inflammatory response is initiated upon fracture through hematoma by (day=D) D3, 
leading to cartilaginous callus formation within D7, which serve basis for the new bone 
formation. The cartilage shows chondrocytes hypertrophy by D10 marking the initiation of 
ossification and continues until D14. A bony bridged callus is formed at D21 and later 
remodeling is initiated in which cortical bone reshape to its original status by D28 († 
adapted from [73]). 
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2.  OBJECTIVES OF THIS STUDY 
Many cellular and molecular events like inflammation, ossification are important for the 
positive regulation of fracture healing. Several different animal models were generated and 
implemented in fracture healing study. This study aims at exploring the progression of 
bone healing using a standardized closed femoral fracture mice model. Different milestone 
of this study are:  
1. Analysis of underlying molecular mechanism behind fracture healing through the 
application of high-throughput sequencing data. 
2. Explain the role of mitochondrial and ribosomal genes in fracture healing. 
3. Role of angiogenesis, ossification, ECM regulation, and immune response in 
successful bone healing.  
4. Examine the role of differentially expressed genes present at each healing event. 
5. Inferring the importance of overlapping genes present between consecutive time 
points. 
6. Evaluation of collagen fibers orientation during progression of healing. 
7. Examine the osteocytes morphological changes in correspondence to bone healing. 
8. Histological evaluation of bone mineralization and extracellular matrix biomarkers. 
9. Explore GPX1 and UBB signal localization and distribution around fractured 
callus and in osteocyte vicinity. 
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3.  MATERIALS AND METHODS 
This work was performed on historical samples, whereas mice housing and operation, 
sample collection, embedding of histological samples as well as RNA extraction, 
hybridization and microarray sequencing were all carried out by members of the Biology 
of Bone Healing team of the Julius Wolff Institute, at the Charité - Universitätmedizin 
Berlin, Berlin, Germany.  
3.1 Experimental Design 
A standard mid diaphyseal closed fracture was generated in the left femora of eight-week-
old male wild type mice (C57BL/6N; Charles River Laboratories, Wilmington, MA, USA) 
using the method developed by Bonnarens and Einhorn [74]. Animals received 2.5% 
isoflurane mixed with oxygen inhalation and subcutaneous injection of 1 mg Buprenorphin 
(Reckitt Benckiser, Ludwigschafen am Rhein, Germany) per kilogram body weight for 
anesthesia before surgery. Under anesthesia, the animals were prepared for surgical 
procedure by shaving and cleaning (Braunoderm®, B. Braun Melsungen AG, Hesse, 
Germany) the left hind limb. The left knee was bent and an incision was made through the 
skin to the middle of patella. The patella was then dislocated laterally to expose the 
femoral condyles. A 0.55 mm sterile hollow needle (BD MicrolanceTM, Becton Dickinson 
Life Sciences, Heidelberg, Germany) was used to create a passage for the intramedullary 
pin through the distal end. Later, the needle was removed to insert an intramedullary pin 
(Thermo spinal needle 17, 0.5 × 0.9 mm, Thermo Europe N. V., Leuven, Belgium) into the 
bone marrow cavity. The cutter was used to adapt the pin length according to the mice 
femur. After the pin alignment, the patella was repositioned and the limb was sutured 
successfully.  
Animals were euthanized at (D = Days, N = 67) D3, D7, D10, D14, D21, and D28 post-
fracture. D0 served as the control for the study of differential gene expression. D7, D10, 
D14, D21, and D28 were used for histological evaluation. Mice were anesthetized and 
euthanized by Carbon dioxide (CO2) inhalation as certified by the regional ethical 
committee. Furthermore, mice were euthanized by cervical dislocation for differential 
gene expression analysis. After euthanasia, the left femurs were cleaned and collected.  
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The animal experiments and sample collection were carried out by members of the 
Biology of Bone Healing team of the Julius Wolff Institute, at the Charité -
Universitätmedizin Berlin, Berlin, Germany. 
3.2 Animal Ethical Declaration 
The study was performed in full compliance with the institutional laws and the German 
animal protection laws. Animal experiments were approved by the Animal Ethics 
Committee in the state of Berlin, Germany (“Landesamt für Gesundheit und Soziales, 
Berlin”, Permit number: G0206/08). 
3.3 Sample Preparation for Histological Evaluation 
After euthanasia, samples were collected and fixed in 4% Paraformaldehyde solution 
(PFA) for 48 hours to perform decalcified histology. Samples collection, infiltration and 
paraffin embedding were carried by members of the Julius Wolff Institute, at the Charité - 
Universitätmedizin Berlin, Berlin, Germany. The detailed embedding protocol is present in 
Appendix 1. The solidified blocks were stored at 4°C for 24 hours before sectioning. A 
motorized rotary microtome (Thermo / Microm HM 355 S, Thermo Scientific GmbH, 
Karlsruhe, Germany) was used to cut 5 µm thick sections. Sections were immediately 
placed in a warm water bath (40°C) to allow stretching. Then, the sections were mounted 
on a glass slide (SuperFrost Plus®, R.Langenbrinck GmbH, Labor- und Medizintechnik, 
Emmendingen, Germany) and dried in an incubator for 24 hours at 37°C. The sectioning 
and subsequent staining were carried out at the Experimental Trauma Surgery of the 
Justus-Liebig-University, Giessen, Germany to fulfill the requirement of this thesis. 
3.4 Histological Staining 
Different histological stains provide visualization and analysis of cellular changes, bone 
mineralization, and extracellular matrix organization. The paraffin embedded sections 
were used to perform the following staining: 
3.4.1 Sirius Red Stain differentiates type I, type II, and type III collagen within a sample 
under polarized light [75]. Type I collagen appears as yellow-red, type II collagen appears 
as blue-light yellow, and type III collagen appears as green. The stain was used to 
investigate the organization and heterogeneity of collagen fibers orientation during callus 
maturation in fracture healing. The detailed staining protocol is present in Appendix 2. 
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3.4.2 Trichrome Masson Goldner Stain differentiates the mineralized and non-
mineralized bone matrix within a sample [76]. Mineralized bone matrix appears as green 
and non-mineralized bone matrix appears as red. The stain was performed to qualitatively 
analyze the changes in bone mineralization with progression of fracture healing process. 
The detailed staining protocol is present in Appendix 3. 
3.4.3 Silver Nitrate Stain differentiates osteocytes and their canaliculi network by 
staining acidic protein present in the bone matrix within a sample.[72]. The stain was used 
to analyze the morphological changes in osteocytes during fracture healing. Active 
osteocytes appears as spindle shaped with canaliculi, intermediated osteocytes appears as 
spherical shaped, and inactive osteocytes appears as empty lacunae. The detailed staining 
protocol is present in Appendix 4. All the histological stains were carried out in 
Experimental Trauma Surgery, at the Justus-Liebig-University Giessen, Giessen, 
Germany. 
3.5 Immunohistochemical Staining 
Immunohistochemical (IHC) stains help in analyzing protein signal activity to describe 
cellular regulation within a sample based on antibody-antigen reactions. Antigens were 
retrieved by pretreating paraffin sections with citrate buffer at 60°C for 1 hour. Following 
IHC stains were performed as indicated in the general protocol present in Appendix 5: 
3.5.1 Alpha Smooth Muscle Actin (ASMA) serve as a biological marker to visualize 
blood vessel formation [77]. The stain was performed to investigate blood vessel 
formation during fracture healing. ASMA labeling was performed using a rabbit 
polyclonal primary antibody dilution in 1:100 ratio and visualized with vector red Alkaline 
phosphatase (AP)-kit (AK 5200, Vectastain ABC kit, Vector Laboratories, Inc., 
Burlingame, CA, USA). The sections were then counter-stained with Methyl Green.  
3.5.2 Matrix Extracellular Phosphoglycoprotein (MEPE) serve as a biological marker 
of ECM formation and bone mineralization [78]. The stain was performed to investigate 
the changes within ECM during fracture healing. MEPE labeling was performed using a 
rabbit polyclonal primary antibody diluted in 1:100 ratio and visualized using vector red 
AP-kit. The sections were then counter-stained with Toluidine Blue.  
3.5.3 Extracellular Signal Regulated Kinase (ERK) serve as a biological marker of cell 
migration and adhesion on ECM [23]. The stain was performed to investigate the changes 
14 
 
within ECM during fracture healing. ERK labeling was performed using a rabbit 
polyclonal primary antibody diluted in 1:100 ratio and visualized using vector red AP-kit. 
The sections were then counter-stained with Toluidine Blue. 
3.5.4 Glutathione Peroxidase 1 (GPX1) serve as a biological marker of oxidative stress 
in cardiovascular diseases [79]. GPX1 is a part of mitochondrion. The stain was performed 
to investigate changes in mitochondrial activity during fracture healing. GPX1 labeling 
was performed using a rabbit polyclonal primary antibody diluted in 1:325 ratio and 
visualized using vector red AP-kit. Two different set of samples were stained using similar 
protocol. One set of sections were then counter-stained with Toluidine Blue to perform 
quantitative evaluation of GPX1 activity in the callus region. The other set of sections 
were counter-stained with Silver Nitrate to investigate the activity of GPX1 in osteocyte 
vicinity.  
3.5.5 Ubiquitin (UBB) serve as a biological marker for proteasome dysfunction in 
neurodegeneration [80]. UBB is a conserved protein involved in ribosome activity. The 
stain was performed to investigate the changes in ribosomal activity during fracture 
healing. UBB labeling was performed using a rabbit polyclonal primary antibody diluted 
in 1:150 ratio and visualized using vector red AP-kit. One set of sections were then 
counter-stained with Toluidine Blue to perform quantitative evaluation of UBB activity in 
the callus region. The other set of sections were counter-stained with Silver Nitrate to 
investigate the activity of UBB in osteocyte vicinity.  
3.6 Image Acquisition and Histomorphometry 
All images were acquired using a Leica microscope (Leica DM5500 photomicroscope 
equipped with DFC7000 camera, LASX software version 3.0; Leica Microsystem Ltd., 
Wetzlar, Germany). All histological stained were imaged using 10X and 40X 
magnification. The sections of GPX1 and UBB counter-stained with Silver Nitrate were 
visualized using Texas-Red filter (Leica Microsystem Ltd., Wetzlar, Germany) at > 560 
nm emission and imaged at oil emersion (100X) magnification. The excitation wavelength 
range was set between 365 to 560 nm for the fluorescent red substrate.  
Sirius red sections were visualized using Leica microscope equipped with additional 
polarized analyzer (11555079, Analyzer 180, Rotatable; Leica Microsystem Ltd., Wetzlar, 
Germany) and lambda filter (11513908, Lambda plate in holder; Leica Microsystem Ltd., 
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Wetzlar, Germany). Analyzer was kept at 150° and lambda plate was kept at 75° for all 
samples. Monochrome and colored images were taken using 10X, 20X, 40X, and oil 
emersion (100X) magnification. 
Histomorphometry was performed using ImageJ software (version 1.51n, National 
Institute of Health, Bethesda, MD, USA). Trainable Weka Segmentation (version 3.2.13) 
[81] plugin was used to calculate tissue area after IHC stains. Cell Counter plugins was 
used to count osteocytes after Silver Nitrate staining. The complete protocol is present in 
Appendix 6. Image capturing and analysis were carried out in the Experimental Trauma 
Surgery, at the Justus-Liebig-University, Giessen, Germany. 
3.7 Quantification of Collagen Fibers 
An automated standalone CT-FIRE (version 2.0 Beta) package from MATLAB (version 
R2017b, MathWorks, Natick, MA, USA) was used to computationally segment collagen 
fibers from Sirius red stained monochrome pictures (Figure 4).. CT-FIRE was used before 
to quantify fibril structure taken from transmission electron microscopy or fluorescence 
microscopy [82, 83].  
 
Figure 4: Application of Sirius red stained images to quantitative evaluate collagen fiber 
orientation using CT-FIRE. This study established the methodology to perform 
quantification of collagen fibers from Sirius red stained images under polarized light. 
3.8 Statistical Analysis 
Descriptive statistics were carried out to test normality of data sets. Data were analyzed 
using IBM SPSS Statistical Package 24.0 (IBM Corporation, Armonk, NY, USA). One-
way analysis of variance (ANOVA) test with Bonferroni correction was used for 
parametric distribution (Fiber width, straightness, and angle). Significance analysis for 
non-parametric distribution was performed using Mann Whitney U-test (Fiber length, 
histomorphometry). Bar graphs were presented as Mean ± Standard Error of Mean (SEM). 
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3.9 RNA Preparation and Microarray Hybridization 
After euthanasia, samples were collected for RNA isolation. Collected tissues were 
circumscribed by 1 mm on either side of the fracture callus. Tissues were flash frozen in 
liquid nitrogen and stored at -80°C until used for RNA extraction. During sample 
preparation, tissues were pulverized using pestle and mortar under continuous cooling with 
liquid nitrogen and then homogenized in TRIZOL using T10, Ultraturrax while placed on 
ice. Following homogenization, total RNA was isolated from samples using TRIZOL as 
per the manufacturer's protocol (Invitrogen Life Technologies, Berlin, Germany) including 
DNAse I (Invitrogen Life Technologies, Berlin, Germany) digestion. 150 ng of each RNA 
samples per group were taken and mixed in a given pooled and RNA mix was distributed 
into three vials (200 ng each) for microarray analysis.  
Transcriptome profiling was performed using Illumina's MouseRef-8 v2.0 Expression 
Bead Chips (Illumina, Ambion, TX, USA). RNA processing for cRNA synthesis and 
labeling was done according to standard protocols as described in the user manual of 
Illumina TotalPrep RNA amplification kit (Illumina, Ambion, TX, USA). Hybridization of 
the labeled and fragmented cRNA to the microarray and subsequent staining, washing and 
scanning of the arrays were done as instructed in the Illumina Whole-Genome Gene 
Expression direct Hybridization Assay guide.  
RNA isolation and microarray hybridization were carried out by the members of the 
Biology of Bone Healing team of the Julius Wolff Institute, at the Charité -
Universitätmedizin Berlin, Berlin, Germany. The detailed RNA isolation protocol is 
present in Appendix 7. 
3.10 Data Normalization and Filtering Criteria 
The raw data was analyzed using the R project for Statistical Computing (version 3.0.3). 
Different packages provided by Bioconductor (version 3.5) were used to process and 
normalize the array files. Illumina whole genome sequencing generated IDAT files that 
store the intensity values of each probe. Illuminaio package [84] was used to read the 
IDAT files. Bead array package [85] was used to read the intensity data and perform 
background corrections and normalization. Limma package [86] was used to analyze 
differential expression in microarray data. Quintiles were normalized between array using 
above mentioned packages. Quality assessment of array data was carried out by 
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calculating Pearson’s correlation coefficient between arrays. Fold Change (FC) was 
calculated as the differences between each post-fracture day (D3, D7, D10, D14, D21, and 
D28) and D0. The significance level (P-value) was calculated using a two-tailed student t-
test. The script used for quality assessment is present in Appendix 8. The microarray data 
analysis was carried out in the Experimental Trauma Surgery, at the Justus-Liebig-
University, Giessen, Germany as a part of this thesis. 
3.11 Clustering of Differentially Expressed Genes 
Clustering of genes based on the expression pattern identifies co-regulated and 
functionally related genes. Hierarchical clustering method using R (version 3.0.3) and 
Bioconductor packages was implemented to obtain set of DEG with similar expression 
profile. The script used for hierarchical clustering is present in Appendix 9. 
3.12 Functional Annotation of Differentially Expressed Genes 
Functional annotation of genes provides an insight to the molecular function, cellular 
component, and biological process. An online server; Database for Annotation, 
Visualization and Integrated Discovery (DAVID) bioinformatics database (version 6.7, 
https://david.ncifcrf.gov/) [87] provides an integrated and updated information about the 
involved molecular function, cellular component, and biological processes for gene of 
interest. Furthermore, DAVID provides an option of functional annotation clustering to 
cluster functionally similar terms associated with gene list. DAVID analysis was 
performed to investigate the role of DEG during fracture healing. The set of genes 
obtained after hierarchical clustering were functionally clustered using DAVID with 
enrichment score ≥ 1.5. Enrichment score is a method to identify the over-represented 
functional annotation terms for gene clusters. The detailed protocol used is present in 
Appendix 10. 
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4.  RESULTS 
4.1 Comparison of FC cut-offs resulted in no variation in DEG pattern 
FC and P-value are the standard cut-offs criteria to analyze DEG in microarray data. 
However, a P-value of 0.01 is favorable over a 0.05 value. Therefore, discrepancies in data 
can result from the implemented FC. Although literature reports FC cut-offs of |1|, |1.5|, 
and |2| as acceptable, but the resulting pattern variation was not addressed. Therefore, 
differences in pattern change with FC cut-offs were investigated. The obtained DEG from 
each FC were functionally annotated and six highly represented biological processes were: 
angiogenesis, ossification, ECM, immune response, mitochondrial, and ribosomal activity. 
The percentage distribution of biological processes was plotted in pie charts separately for 
upregulated and downregulated genes (Figure 5). 
Expectedly the number of DEGs negatively correlated with FC value. FC cut-off of |1|, 
|1.5|, and |2| resulted in 2949, 1235, and 379 DEG respectively. Nonetheless, overlapping 
genes were observed between upregulated and downregulated panel at all FC cut-offs 
(Table 1). 
Table 1: Number of differentially expressed genes and overlapping genes at each FC 
cut-off  
FC cut-offs No. of DEG No. of upregulated 
genes 
No. of downregulated 
genes 
No. of overlapping 
genes 
|1| 2650 1138 1314 198 
|1.5| 1106 374 699 33 
|2| 438 122 309 7 
Among the upregulated panel, 18% of angiogenesis genes were present at FC ≥ |1|, the 
percentage declined to 8% at FC ≥ |1.5|, and then further to 7% at FC ≥ |2| (Figure 5 A, C, 
E). Furthermore, 14% of ossification genes were present at FC ≥ |1|, whereas the 
percentage increased to 21% at FC ≥ |1.5|, and then further increased to 27% at FC ≥ |2|. 
ECM genes occupied 17% at FC ≥ |1|, 24% at FC ≥ |1.5|, and 27% at FC ≥ |2| (Figure 5 A, 
C, E).  
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Figure 5: Higher cut-off reduce the number of genes without affecting gene ontology 
prediction. FC cut-offs of |1|, |1.5|, and |2| along with P-value ≤ 0.01 were investigated to 
address pattern variation. FC ≥ |1| and FC ≥ |1.5|, (A, B) showed higher percentage of 
immune response genes in upregulated panel, and (D, E) higher percentage of 
mitochondrial genes in downregulated panel. At FC ≥ |2|, (C) 27% of each of immune 
response, ECM, and ossification genes were present in upregulated panel, (F) highest 
percentage of mitochondrial genes were present in the downregulated panel. (FC: fold 
change). 
Interestingly, immune response genes showed higher percentage of 37% and 36% at FC ≥ 
|1| and FC ≥ |1.5|, respectively (Figure 5A). While, the percentage of immune response 
genes declined to 27% at FC ≥ |2|. Furthermore, 11% of mitochondrial genes were present 
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at FC ≥ |1|, the percentage decreased to 9% at FC ≥ |1.5|, and then to 8% at FC ≥ |2| 
(Figure 5 A, C, E). Ribosomal genes showed lower percentage at all FC cut-off in 
upregulated panel. 3% of ribosomal activity related genes were present at FC ≥ |1|, the 
percentage declined to 2% at FC ≥ |1.5|, and then further increased to 4% at FC ≥ |2|.    
Among the downregulated panel, 7% of angiogenesis genes were present at FC ≤ |1|, the 
percentage increased to 11% at FC ≤ |1.5|, and then declined to 5% at FC ≤ |2| (Figure 5 B, 
D, F). Furthermore, 4% of ossification genes were present at FC ≤ |1| and FC ≤ |1.5|, and 
then the percentage increased to 8% at FC ≤ |2|. ECM genes showed 4% at FC ≤ |1|, 
percentage increased to 5% at FC ≤ |1.5|, and then decreased to 3% at FC ≤ |2| (Figure 5 B, 
D, F). Immune response genes were 25% at FC ≤ |1|, 18% at FC ≤ |1.5|, and 22% at FC ≤ 
|2|. Interestingly, mitochondrial genes showed higher percentage at all FC cut-off in the 
downregulated panel (Figure 5 B, D, F). Mitochondrial genes were 51%, 56%, and 59% at 
FC ≤ |1|, FC ≤ |1.5|, and FC ≤ |2| respectively (Figure 5 B, D, F). Furthermore, 4% of 
ribosomal genes were present at FC ≤ |1|, the percentage increased to 6% at FC ≤ |1.5|, and 
then decreased to 3% at FC ≤ |2|. 
Despite the decline in number of DEG, the biological processes with highest 
representation remained the same in upregulated and downregulated panels. Immune 
response genes occupied higher percentage at FC ≥ |1| and FC ≥ |1.5| in the upregulated 
panel when compared to other processes (Figure 5). Whereas at FC ≥ |2|, immune 
response, ECM, and ossification genes showed equal percentage of 27%. Mitochondrial 
genes showed more than 50% at all FC cut-offs in the downregulated panel (Figure 5 B, D, 
F). Choice of higher FC cut-off provided with list of highly affected genes. Therefore, 
further analysis was performed using FC ≥ |2| and P-value ≤ 0.01 cut-off. 
4.2 Overlapping genes between two consecutive time points: hallmark 
either by mitochondrial activity or by ECM regulation 
Fracture healing process represents a series of overlapping cellular events. Genes present 
in two consecutive time points, regardless if up- or down-regulated, were taken as 
overlapping gene list. Investigating overlapping genes aimed to understand overlapping of 
healing phases. Obtained overlapping gene lists were functionally annotated and highly 
representative biological processes obtained were: angiogenesis, ossification, ECM, 
immune response, mitochondrial, and ribosomal activity. Furthermore, the percentage 
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distribution of biological processes in the consecutive time points were presented in pie-
charts (Figure 6). 
201 and 212 genes were differentially expressed at D3 and D7, respectively. 181 common 
(overlapping) genes were expressed at D3 as well as D7 (Figure 6A). Functional 
annotation of overlapping genes showed higher percentage (40%) of mitochondrial genes 
(Figure 6B). 20% of ECM and 16% of immune response genes were present in overlap of 
D3 & D7. Ossification, angiogenesis, and ribosomal genes were present in equal 
percentage (8%) in overlap of D3 & D7 (Figure 6B). 
212 and 146 genes were differentially expressed at D7 and D10, respectively. 22 
overlapping genes were present at D7 and D10 (Figure 6A). Overlapping genes between 
D7 and D10 showed higher percentage (44%) of ECM genes (Figure 6B). 25% of 
ossification genes and 19% of mitochondrial genes were present between D7 & D10. 12% 
of immune response genes were present in overlap of D7 & D10. No genes involved in 
angiogenesis or ribosomal activity were present in overlap of D7 and D10 (Figure 6B). 
146 and 132 genes were differentially expressed at D10 and D14, respectively. 91 genes 
overlapped between D10 and D14 (Figure 6A). Functional annotation of overlapping 
genes showed higher percentage (44%) of ECM genes (Figure 6B). 20% of immune 
response genes and 17% of ossification genes were present between D10 & D14. 
Furthermore, 13% of mitochondrial genes were present between D10 & D14 overlap. 4% 
of ribosomal genes and 2% of angiogenesis genes were present in the overlap of D10 & 
D14 (Figure 6B). 
132 and 34 genes were differentially expressed at D14 and D21, respectively. 16 genes 
overlapped between D14 and D21 (Figure 6A). Overlapping genes between D14 and D21 
showed higher percentage (41%) of ECM genes (Figure 6B). 29% of ossification genes 
and 18% of immune response genes were present between D14 & D21. 12% of 
mitochondrial genes were present between D14 & D21 overlap (Figure 6B). 
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Figure 6: Functional annotation of overlapping genes between consecutive time points 
showed higher percentage of mitochondrial and ECM genes. DEG list between two 
consecutive time points were compared to understand differential regulation throughout 
the healing process. (A) Venn diagram depicts the number of overlapping genes between 
every two consecutive time points. D3 & D7 showed highest number of overlapping genes. 
Number of DEGs were higher at D3, D7, D10, and D14 when compared to D21 and D28. 
(B) Functional annotation showed higher percentage of mitochondrial genes at D3 and 
D7. Higher percentage of ECM genes were differentially expressed at D7, D10, D14, and 
D21. 
34 and 26 genes were differentially expressed at D21 and D28, respectively. 17 genes 
overlapped between D21 and D28 (Figure 6A). Immune response genes showed higher 
percentage (37%) in D21 and D28 overlap (Figure 6B). ECM, ossification, and ribosomal 
genes were present in equal percentage (18%) between D21 & D28. 9% of mitochondrial 
genes were present in D21 & D28 overlap (Figure 6B). 
The comparison of consecutive time points showed highest number of overlapping genes 
present between D3 and D7 when compared to other overlapping time points. 
Furthermore, functional annotation showed the higher percentage presence of 
mitochondrial genes between D3 and D7. Whereas higher percentage of ECM genes were 
present between D7 & D10, D10 & D14, and D14 & D21 (Figure 6B). The detailed 
understanding of differential gene expression across time points is required, which 
instigated use of clustering algorithm. 
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4.3 Hierarchical clustering of genes based on expression pattern across 
time points generated ten distinct clusters 
Hierarchical clustering was performed to investigate the changes in expression pattern of 
genes across time points of healing. DEGs present in at least one time point were used for 
hierarchical clustering. Genes present in each cluster were visualized in a heatmap (Figure 
7, left panel). The obtained set of genes (clusters) were then functionally annotated (Figure 
7, right panel). 
Hierarchical clustering resulted in ten distinct clusters. Genes of the first, fifth, sixth, and 
tenth cluster were downregulated at all time points (Figure 7, left panel). 66 genes were 
present in first cluster and 21 genes were present in fifth cluster. Genes present in first and 
fifth cluster are related to mitochondrial activity and cytoskeleton organization, 
respectively. 33 genes were present in sixth cluster and 4 genes were present in tenth 
cluster. Genes present in sixth cluster are related to angiogenesis, ECM, and bone 
mineralization (Figure 7, right panel). Whereas, genes present in tenth cluster are related to 
cell repair activity. Furthermore, genes of the second, third, fourth, and ninth cluster were 
upregulated only at D10 and D14 whereas downregulated at other time points. 150 genes 
were present in second cluster. Genes in second cluster are related to ribosomal proteins, 
ECM, and innate immunity (Figure 7, right panel). 5 genes and 13 genes were present in 
third and ninth cluster, respectively. Genes in the third and ninth cluster are related to 
mitochondrial activity. 58 genes were present in fourth cluster. Genes in fourth cluster are 
related to bone mineralization, ECM, and immune response (Figure 7, right panel). Genes 
in seventh cluster were upregulated only at D14 while downregulated at all other time 
points (Figure 7, left panel). 14 genes were present in seventh cluster. Genes in the seventh 
cluster are related to glycolysis and post-translational activity. Genes in eighth cluster were 
upregulated only at D14 and D21 whereas downregulated at other time points. 33 genes 
were present in eighth cluster. Genes in the eighth cluster are related to cell adhesion, 
transcription, and ossification (Figure 7, right panel).  
Among 66 genes within first cluster, several important genes crucial for ECM, bone 
homeostasis, and ribosomal proteins were differentially expressed. Genes like 3-Oxoacid 
CoA-Transferase 1 (Oxct1) which is needed for ketone body catabolism and Ubiquitin B 
(Ubb) which is required for translational activity were present in first cluster.  
24 
 
Among 150 genes within second cluster, several important genes crucial for ribosomal 
activity, immune response, and ECM were differentially expressed. Ribosomal protein s6 
(Rps6) and Ribosomal protein s3 (Rps3) required for protein synthesis and 
phosphorylation were present in second cluster.  
Among 5 genes within third cluster, Adenosine triphosphate synthase subunit beta, 
mitochondrial (Atp5b) which encodes for ATP synthesis and transport was differentially 
expressed. 
Among 58 genes within fourth cluster, several important genes crucial for bone 
mineralization, ECM, and immune response were differentially expressed. Genes like 
Integrin binding sialoprotein (Ibsp) and Matrix gla protein (Mgp) that are crucial for 
ossification were present in fourth cluster.  
Among 21 genes within fifth cluster, several important genes crucial for cytoskeleton 
organization and ECM were differentially expressed. Genes like Myomesin 1 (Myom1) 
which is required for muscle contraction and Calpain small subunit 1 (Capns1) which is 
required for cell proliferation were present in fifth cluster.  
Among 33 genes within sixth cluster, several important genes crucial for angiogenesis and 
bone mineralization were differentially expressed. Genes including blood vessel formation 
marker like Vascular endothelial growth factor alpha (Vegfa) and bone matrix 
mineralization marker like Secreted phosphoprotein 1 (Spp1) were present in sixth cluster.  
Among 14 genes within seventh cluster, genes that encode for protein synthesis within 
mitochondrion like Mitochondrial Ribosomal Protein l53 (Mrpl53) and Cytochrome c 
oxidase assembly homolog 19 (Cox19) were differentially expressed. 
Among 33 genes within eighth cluster, several important genes crucial for transcription 
and ossification were differentially expressed. Genes like Ribosomal protein s2 (Rps2) and 
Matrix metalloproteinase 13 (Mmp13) that are required for protein translation and tissue 
remodeling, respectively were present in eighth cluster.  
Among 13 genes within ninth cluster, genes like Cytochrome c1 (Cyc1) and Voltage 
dependent anion channel 1 (Vdac1) that encode for respiratory chain were differentially 
expressed. 
Among 4 genes within tenth cluster, gene like Minichromosome maintenance complex 
component 7 (Mcm7) which encodes for DNA replication was differentially expressed. 
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The results showed higher number of downregulated genes at D3 and D7 when compared 
to other time points. Whereas, higher number of upregulated genes were present at D10 
and D14 when compared to other time points. Furthermore, hierarchical clustering and 
functional annotation showed presence of mitochondrial and ECM related activity in more 
than two clusters (Figure 7, right panel). The global overview of differential gene 
expression across time points instigated further investigation of gene expression at each 
time point of study.  
Figure 7: Hierarchical clustering aligned genes into ten distinct clusters based on 
expression pattern 
across time points of 
healing. Hierarchical 
clustering was 
performed to group 
genes based on 
expression pattern 
during healing. Ten 
distinct clusters were 
obtained. Genes 
present in clusters 
were visualized in 
Heatmap (left panel). 
Red and green 
indicates the color 
key from 
downregulation to 
upregulation of genes 
compared to D0, 
respectively. Further, 
functional annotation 
of genes present in 
each cluster was 
performed using 
NCBI-DAVID (right 
panel). ECM and 
mitochondrial genes 
were present in many clusters. (N = 5/time point, FC: fold-change).  
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4.4 D3 and D7 marked the active phase of differentially expressed 
angiogenesis genes 
Injury initiates inflammatory phase which is crucial for the progression of fracture healing. 
Simultaneously blood supply and revascularization are essential for a successful fracture 
healing. Differentially expressed genes involved in angiogenesis were analyzed to 
understand the underlying molecular mechanism of fracture healing.  
In total 12 angiogenesis related genes were differentially expressed during course of 
healing, 7 genes were downregulated and 5 genes were upregulated (Table 2).  
Among downregulated genes, there were angiogenic factors like Vascular endothelial 
growth factor A (Vegfa), Pleiotrophin (Ptn) and anti-angiogenic factor like Decorin (Dcn). 
Vegfa and Dcn were significantly downregulated at D3 and D7 only. Whereas, Ptn was 
significantly downregulated at D3, D7, D21, and D28. Endothelial cell migration and 
maintenance of oxidative stress is crucial during angiogenesis and fracture healing. Genes 
like Aquaporin 1 (Aqp1) which encodes for cell migration and Gpx1 which diminishes 
oxidative stress condition were significantly downregulated at D3 and D7. Furthermore, 
gene like Matrix metalloproteinase 2 (Mmp2) which degrades ECM to enhance blood 
vessel formation was significantly downregulated at D3 and D7. Mapk14 plays an 
important role in MAPK signaling and was significantly downregulated at D3 and D7.  
Among upregulated genes, there were anti-angiogenic factor like Serpin family f member 
1 (Serpinf1) and ECM anchorage protein like Matrix metalloproteinase 9 (Mmp9). 
Serpinf1 was significantly upregulated at D3 and D7. Whereas Mmp9 was significantly 
upregulated at D10, D14, and D21. Furthermore, genes like Transforming growth factor 
beta receptor 1 (Tgfbr1) and Transforming growth factor beta receptor 2 (Tgfbr2) that 
stimulate angiogenesis process were significantly upregulated at D14 and D10, 
respectively. Stress condition activates Secreted protein acidic and cysteine rich (Sparc) 
which is crucial for cell proliferation and development. Sparc was significantly 
upregulated at D10. 
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Table 2: List of differentially expressed angiogenesis genes and their FC and P-value 
(white background: downregulated and grey background: upregulated)  
Gene D3 D7 D10 D14 D21 D28 
V
eg
fa
 -2.313 -2.236     
6.46E-05 1.91E-04     
P
tn
 
-2.374 -2.2878   -2.179 -2.292 
2.17E-05 4.64E-05   6.65E-05 1.34E-05 
D
cn
 -2.35442 -2.373     
3.14E-04 3.10E-04     
A
q
p
1
 -2.39845 -2.32452     
5.61E-06 2.21E-05     
G
p
x
1
 -2.95 -3.164     
7.9E-06 8.9E-06     
M
m
p
2
 -2.094 -2.262     
1.07E-05 5.92E-05     
M
ap
k
1
4
 -2.713 -2.759     
2.16E-05 1.43E-04     
S
er
p
in
f1
 
2.386 2.196     
8.1E-07 2.65E-05   
  
M
m
p
9
   2.3381 2.34614 2.19513 
 
  1.30E-05 1.26E-05 5.35E-06 
 
T
g
fb
r1
    2.1474   
   3.79E-05   
T
g
fb
r2
   2.042  
  
  7.46E-05  
  
S
p
ar
c 
  2.9793    
  1.85E-06    
 
The investigation of angiogenesis genes showed highest number of differentially 
expressed genes at D3 and D7 compared to other time points. Further understanding of 
angiogenesis during fracture healing requires histological evaluation of blood vessels. 
28 
 
4.5 Evaluation of ASMA activity during fracture healing showed higher 
positive signal at D7 
ASMA serve as a biological marker for blood vessel visualization. Therefore, analysis of 
vascularization around callus was performed using ASMA immunohistochemistry (Figure 
8). ASMA positive area and blood vessels count were evaluated and then normalized to 
total callus area (Figure 8 B, D).  
Descriptively, blood vessels were located within the fractured gap and endosteum region 
both at D7 and D10 (Figure 8A). While at D14, blood vessels were detected within the 
mineralized matrix present in periosteal region. Furthermore, blood vessels were located 
mainly near the cortices at D21. Blood vessels were detected within bone marrow and 
newly formed bone at D28 (Figure 8C).  
Histomorphometry showed higher ASMA positive area at D7 when compared with other 
time points (Figure 8B). Furthermore, D21 showed lower ASMA positive area when 
compared with other time points. ASMA positive area showed variation at D10, D14, and 
D28 but no significant differences were observed (Figure 8B). Blood vessels count was 
higher at D7 when compared with other time points (Figure 8D). Furthermore, D21 
showed lower blood vessels count compared with other time points. While, blood vessels 
count fluctuated between D10, D14, and D28 (Figure 8D). Blood vessels count was 
significantly higher at D7, D10, and D28 when compared with D21 (p = 0.017, 0.003, 
0.022, respectively). The formation of blood vessels during initial phase provides the 
suitable environment required for fracture healing, thereby initiating the calcification of 
cartilage and replacement with new bone. Therefore, detailed understanding of fracture 
healing process requires the investigation of differentially expressed ossification genes.  
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Figure 8: Quantitative analysis of ASMA signal during fracture healing showed higher 
signal at D7.  ASMA immunohistochemistry was performed to analyze blood vessel 
formation during fracture healing. Histomorphometry was performed to evaluate ASMA 
positive area and blood vessels count. Methyl Green was used as counter-stain. (A) 
Positive stained regions were located near the fractured gap at D7. (B) D7 showed the 
higher ASMA area and D21 showed the lower ASMA area higher and lower ASMA area. 
(C) ASMA stained regions at D28 were seen near the newly formed bone. (D) Blood 
vessels count was higher at D7 and lower at D21 compared with other time points. D7, 
D10, and D28 showed significantly higher blood vessels count when compared with D21 
(N = 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 (D21, D28); Non-parametric distribution, 
Mann-Whitney U-test, * = p ≤ 0.05, BV: blood vessels). 
4.6 D10 and D14 marked the active time points with differentially expressed 
ossification genes 
The restoration of blood supply at the fracture site provides different cellular signal 
required for new bone formation. Ossification is an important process which involves 
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resorption of primary soft cartilaginous callus, which later get replaced by hard bony 
callus. Therefore, differential expression of genes involved in ossification were examined 
to understand the underlying molecular mechanism of fracture healing. 
In total 13 ossification related genes were differentially expressed, 2 genes were 
downregulated and 11 genes were upregulated (Table 3). 
Among downregulated genes, there were genes like Ubb and Myocyte enhancer factor 2c 
(Mef2c) that encode chondrocytes hypertrophy. Ubb was significantly downregulated at 
D3 and D7, while Mef2c was significantly downregulated at D10 and D14. 
Among upregulated genes, there were collagen family genes like Collagen type 1 alpha 1 
(Col1a1), Collagen type 10 alpha 1 (Col10a1), and Collagen type 2 alpha 1 (Col2a1) that 
are important for bone mineralization. Col1a1 was significantly upregulated at D10, D14, 
and D21. Col10a1 was significantly upregulated only at D10. Col2a1 was significantly 
upregulated at D10 and D14. Furthermore, Mmp’s family genes like Mmp9 and Mmp13 
that play important role during bone formation and remodeling were also significantly 
expressed. Mmp9 was significantly upregulated at D10, D14, and D21. While, Mmp13 
was significantly upregulated from D3 through D7, D10, D14 until D21. Additionally, a 
Tissue inhibitor of metalloproteinase 1 (Timp1) was significantly upregulated at D3, D7, 
and D21. Endochondral ossification related genes like Cathepsin k (Ctsk) and Specificity 
protein 7 (Sp7) were significantly expressed. Ctsk was significantly upregulated at D10, 
D14, and D21. 
Sp7 was significantly upregulated at D3, D7, and D14. Further, Mgp which inhibits bone 
mineralization was significantly upregulated only at D10. Gene like Spp1 which stimulates 
bone formation and osteoclast anchorage was significantly upregulated at D10 and D14. 
Another important gene was Integrin binding sialoprotein (Ibsp) that binds to 
hydroxyapatite providing stiffness and strength to bone. Ibsp was significantly upregulated 
from D3 through D7, D10, D14 until D28. 
Table 3: List of differentially expressed ossification genes and their FC and P-value 
(white background: downregulated and grey background: upregulated)  
Gene D3 D7 D10 D14 D21 D28 
U
b
b
 -3.837 -3.823     
5.82E-08 3.13E-06     
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M
ef
2
c   -2.582 -3.08   
  8.99E-05 1.67E-04   
C
o
l1
a1
   3.073 2.745 2.038  
  7.99E-06 1.16E-05 3.86E-05  
C
o
l1
0
a1
   3.1519    
  2.21E-07    
C
o
l2
a1
   5.08 2.982   
  9.26E-08 8.81E-06   
M
m
p
9
   2.3381 2.34614 2.19513 
 
  1.30E-05 1.26E-05 5.35E-06 
 
M
m
p
1
3
 2.05 2.166 2.235 2.36 2.291  
4.11E-06 3.73E-06 5.46E-05 3.83E-06 1.90E-06  
T
im
p
1
 2.2396 2.2505   2.2906  
2.55E-05 1.02E-05   4.71E-06  
C
ts
k
   2.6148 2.54762 2.26895  
  3.75E-06 5.01E-06 2.20E-05  
S
p
7
 
2.867 2.833  2.107   
4.85E-07 9.27E-05  3.04E-06   
M
g
p
   2.119    
  1.62E-06    
S
p
p
1
   2.434 2.313   
  3.51E-04 5.41E-04   
Ib
sp
 3.345 3.379 2.821 3.008 2.956  
9.05E-06 8.26E-05 3.40E-05 3.00E-04 2.51E-05  
 
High number of ossification genes were significantly upregulated at D10 and D14 when 
compared to other time points. No differentially expressed gene related to ossification 
were present at D28. Furthermore, the investigation of bone mineralization during fracture 
healing process is required.  
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4.7 Trichrome Masson Goldner depicted changes in bone mineralization 
with progression of fracture healing process 
Trichrome Masson Goldner stain differentiates mineralized bone matrix from non-
mineralized bone matrix. Therefore, changes in bone mineralization were visualized using 
Trichrome Masson Goldner stain (Figure 9).  
Descriptively, cartilaginous callus was formed around the fracture gap and chondrocytes 
were seen in the callus at D7 (Figure 9A). Furthermore, non-mineralized bone matrix 
portion was higher compared to mineralized bone matrix portion at D7 (Figure 9A). D10 
showed an increase in the size of cartilaginous callus and mineralized bone matrix portion 
when compared with D7 (Figure 9 A, B). Proliferative chondrocytes in callus region and 
initiation of mineralization in periosteal region were seen at D10 (Figure 9B).  
A smaller cartilaginous callus was seen at D14 when compared with D10 (Figure 9 B, C). 
Hypertrophic chondrocytes were seen within the callus at D14 (Figure 9C). Mineralized 
bone matrix portion increased at D14 when compared with D7 and D10 (Figure 9 A, B, 
C). Furthermore, non-mineralized bone matrix were seen in small patches within the callus 
region. D21 showed the mineralization of callus borders (Figure 9D). Furthermore, portion 
of cartilage was replaced by newly formed bone by D21. While, small patches of non-
mineralized bone matrix were seen in the callus and endosteum region. The complete 
mineralized bone matrix was formed by D28 (Figure 9E). Nonetheless, bridging of 
cortices were seen.  
Mineralized bone matrix provides structural rigidity and mechanical support to the bone. 
Further work is required to understand the differential expression of ECM genes during 
fracture healing.  
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Figure 9: Trichrome Masson Goldner stain provided an overview of mineralized and 
non-mineralized bone matrix around fractured callus. Masson Goldner stain was 
performed to understand the progression of bone mineralization in fracture healing. (A) 
D7 showed higher portion of non-mineralized matrix compared with other time points, (B) 
D10 showed an initiation of bone mineralization in periosteal. (C) D14 showed an 
increase in mineralized bone matrix and less chondrocytes. (D) D21 showed the 
mineralization of cartilage in the cortices. (E)  D28 showed the complete mineralization 
and bridging of fracture gap. (green: mineralized, red: non-mineralized, chondrocytes: 
grey, blood vessels: red, min: mineralized, non-min: non-mineralized, BM: bone marrow, 
ch: chondrocytes). 
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4.8 D10 marked the active time point related to differentially expressed 
ECM genes 
ECM provides a natural scaffold for bone mineralization and serve as a reservoir of 
growth factors and cytokines. Therefore, differentially expressed genes involved in ECM 
related activity were investigated to understand the regulatory role of ECM during fracture 
healing. 
In total 29 ECM genes were differentially expressed, 6 genes were downregulated and 22 
genes were upregulated (Table 4). Lysyl oxidase (Lox), which plays a role in post-
translational modification of collagens was significantly downregulated at D3 while 
significantly upregulated at D10 and D14. 
Among downregulated genes, there were ECM degradation markers like Mmp2 and ECM 
deposition factor like Osteoglycin (Ogn). Both Mmp2 and Ogn were significantly 
downregulated at D3 and D7. Proteoglycans like Dcn and Lumican (Lum) that are crucial 
for ECM structural integrity were also differentially expressed. Both Dcn and Lum were 
significantly downregulated at D3 and D7. One collagen family gene; Collagen type 12 
alpha 1 (Col12a1) was significantly downregulated at D7. Another important gene for 
matrix mineralization is Ptn which contributes in interaction with mesenchymal stem cells. 
Ptn was significantly downregulated at D3, D7, D21, and D28.   
Among upregulated genes, there were ECM markers like Mmp13 and Mmp9 that are 
crucial for cell differentiation and invasion. Mmp13 was significantly upregulated from 
D3 through D7, D10, D14 until D21. While, Mmp9 was significantly upregulated at D10, 
D14, and D21. Genes like Ibsp and Timp1 that regulate ECM deposition were also 
differentially expressed. Ibsp was significantly upregulated from D3 through D7, D10, 
D14 until D21. While, Timp1 was significantly upregulated at D3, D7, and D21. 
Furthermore, genes like Tgfbr1 and Tgfbr2 that are crucial for ECM production through 
TGF-beta signaling were upregulated. Tgfbr1 was significantly upregulated at D14 while 
Tgfbr2 was significantly upregulated at D10. Sh3 and Px domain containing protein 2b 
(Sh3pxd2b) and Epidermal growth factor containing fibulin ECM protein 2 (Efemp2) play 
an important role in cell matrix adhesion during connective tissue development. Both 
genes were significantly upregulated at D3 and D7. Mgp helps in ECM modeling and was 
only significantly upregulated at D10. While, gene like Tenascin c (Tnc) which helps in 
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ECM development was significantly upregulated at D10 and D14. Furthermore, ECM 
structural component like Aggrecan (Acan) and ECM degradation marker like Cartilage 
associated protein (Crtap) were significantly upregulated at D10. ECM protein like Spp1 
was significantly upregulated at D10 and D14. Further, balanced bone formation and bone 
remodeling process relies on Wnt signaling and Carboxypeptidase Z (Cpz) is crucial for 
binding to Wnt. Cpz was significantly upregulated at D10 and D14. Many collagen family 
genes like Collagen type 24 alpha 1 (Col24a1), Collagen type 6 alpha 1 (Col6a1), Col1a1, 
Col1a2, Col10a1, Collagen type 9 alpha 2 (Col9a2), and Col2a1 were significantly 
upregulated. Col24a1 was significantly upregulated at D7 only while Col6a1 was 
significantly upregulated at D10 only. Col1a1 was significantly upregulated at D10, D14, 
and D21. Col1a2 was significantly upregulated from D3 through D7, D10 until D14. 
Furthermore, Col10a1 was significantly upregulated at D10. Col9a2 and Col2a1 were 
significantly upregulated at D10 and D14. Arrangement of collagen fibers provides the 
higher tensile strength to bone. Gene like Sparc which associates with collagen fiber 
assembly was significantly upregulated at D10.  
Higher number of ECM genes were differentially expressed at D3, D7, D10, and D14 
compared to D21. Collagens are one of the main component of bone matrix. Therefore, 
evaluation of changes in collagen fibers orientation and distribution with the progression 
of healing is required. 
Table 4: List of differentially expressed ECM genes and their FC and P-value (white 
background: downregulated and grey background: upregulated)  
Gene D3 D7 D10 D14 D21 D28 
M
m
p
2
 
-2.094 -2.262     
1.07E-05 5.92E-05     
O
g
n
 -2.401 -2.078     
3.72E-05 2.20E-03     
D
cn
 -2.354 -2.373     
3.14E-04 3.10E-04     
L
u
m
 -3.642 -3.55     
2.22E-05 1.7E-03     
C
o
l1
2
a1
  -2.052     
 4.80E-04     
P
tn
 
-2.374 -2.287   -2.179 -2.292 
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2.17E-05 4.64E-05   6.65E-05 1.34E-05 
M
m
p
1
3
 2.05 2.166 2.235 2.36 2.291  
4.11E-06 3.73E-06 5.46E-05 3.83E-06 1.90E-06  
M
m
p
9
   2.338 2.346 2.195  
  1.30E-05 1.26E-05 5.35E-06  
Ib
sp
 3.345 3.379 2.821 3.008 2.956  
9.05E-06 8.26E-06 3.40E-05 3.00E-04 2.51E-05  
T
im
p
1
 2.239 2.25   2.29  
2.55E-05 1.02E-05   4.71E-06  
T
g
fb
r1
    2.147   
   3.79E-05   
T
g
fb
r2
   2.042    
  7.46E-05    
S
h
3
p
x
d
2
b
 
2.1583 2.0547     
3.02E-06 6.34E-06     
E
fe
m
p
2
 
2.04 2.1007     
2.70E-06 9.64E-06     
M
g
p
   2.119    
  1.62E-06    
T
n
c 
  2.811 2.585   
  7.41E-08 1.67E-06   
A
ca
n
   3.268    
  1.54E-07    
C
rt
ap
   2.166    
  8.87E-10    
S
p
p
1
   2.434 2.313   
  3.51E-04 5.41E-04   
C
p
z 
  2.404 2.096   
  3.27E-06 4.02E-05   
C
o
l2
4
a1
  2.126     
 2.9E-03     
C
o
l6
a1
   2.019    
  3.81E-06    
C
o
l1
a1
 
  3.073 2.745 2.038  
  7.99E-06 1.16E-05 3.86E-05  
C
o
l1
a2
 
2.322 3.109 2.63 2.88   
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1.81E-04 1.23E-04 9.32E-05 5.28E-05   
C
o
l1
0
a1
 
  3.151    
  2.21E-07    
C
o
l9
a2
 
  2.903 2.148   
  1.36E-05 2.14E-04   
C
o
l2
a1
 
  4.952 3.244   
  7.54E-08 1.39E-05   
S
p
ar
c 
  2.979    
  1.85E-06    
L
o
x
 -2.023  2.164 2.345   
9.3E-03  5.41E-05 4.11E-05   
 
4.9 Changes in collagen fibers arrangement with progression of healing 
Discrepancies in arrangement of collagen fibers reflects on ECM quality. Sirius red stain 
helps in type I, type II, and type III collagen visualization under polarized light. Therefore, 
Sirius red stain was carried out to explore the changes in collagen fibers with progression 
of healing (Figure 10). The current study focused on type I collagen and fibril orientation 
was quantified using CT-FIRE program (Figure 11). 
Descriptively, type I collagen fibers were seen in the soft callus and around the cortices at 
D7. Further, type I collagen fragments were seen within fracture gap at D7. Type I 
collagen at D10 was seen in the periosteal region. Type I collagen distribution changed 
with the healing progression. Both regular and irregular orientation of collagen were seen 
at D14. However, well-aligned and longer collagen fibers were seen in both endosteum 
and periosteum region at D21 and D28. 
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Figure 10: Sirius red stain depicted the arrangement of type I collagen in the 
mineralized bone matrix. Polarized microscopy was carried out to determine the change 
and distribution of type I collagen fibers around fractured callus. (A, A1) Type I collagen 
ring like structure were seen around the osteocytes at all time points. (B, B1) Well-
arranged collagen fibers seen in the bone matrix (Ot: osteocyte). 
The distinct type I collagen fibers were visible around newly formed bone at D28. 
Intriguingly, type I collagen ring like structure were seen around the osteocytes at all time 
points (Figure 10). Besides, the collagen fibers arrangement was seen in the bone matrix 
within the fractured callus region (Figure 10). 
The quantitative segmentation of Sirius red stained monochrome images helped in 
identification of fiber properties embedded within bone matrix. The CT-FIRE standalone 
software calculates the distinct fiber properties (angle, length, width, and straightness) 
(Figure 11). The analysis showed significant differences between the fiber properties 
across time points (Figure 11C). 
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Figure 11: Enhanced collagen fiber properties reflected on bone matrix quality at D28. 
CT-FIRE tool was used to quantify the collagen fibers from Sirius red stained images. (A) 
Before segmentation, (B) After segmentation. The right upper side shows the enlarged 
collagen fibers (C-F) D28 showed higher fiber angle, length, width, and straightness when 
compared with D7, D10, D14, and D21. (N = 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 
(D21, D28); Nonparametric distribution, Mann-Whitney U-test, * = p ≤ 0.05). 
Fiber angle points to the orientation of bone mineralization pattern. The fiber angle was 
significantly higher at D28 when compared with D7 (p = 0.013).  
Fiber length is an important parameter in the determination of biomechanical properties 
(Figure 11D). D28 showed significantly longer fibrils when compared with D7 (p = 
0.005), D10 (p = 0.014), D14 (p = 0.007), and D21 (p = 0.001). Fiber width and 
40 
 
straightness governs the collagen networking and anisotropic nature, respectively. Fiber 
width was significantly higher at D28 when compared with D7 (p = 0.042) and D21 (p = 
0.015) (Figure 11E). Fiber straightness showed no significant differences between time 
points (Figure 11F). 
The presence of type I collagen structure around osteocytes encouraged the further 
investigation of osteocytes morphological structure.       
4.10 Quantitative evaluation of osteocytes using silver nitrate stain showed 
lower count at D28  
Osteocyte is a crucial part of ECM, providing mechanical support to bone. Therefore, 
Silver Nitrate stain was used to investigate morphological changes in osteocytes during 
fracture healing (Figure 12). Osteocytes counts were normalized to total callus area. 
Descriptively, all three types of osteocytes: empty lacunae, spherical, and spindle shaped 
were seen around fractured callus (Figure 12A). Osteocytes showed well-connected 
network at all time points.  
Histomorphometry showed higher empty lacunae count at D7 when compared with other 
time points (Figure 12B). D28 showed lower empty lacunae count when compared with 
other time points. Whereas, D10, D14, and D21 showed variation in empty lacunae count 
without significant differences (Figure 12B). D28 showed significantly lower empty 
lacunae count when compared with D10 (p = 0.029) and D21 (p = 0.029).  
Spherical shaped osteocytes count was higher at D7 when compared with other time points 
(Figure 12C). While, D28 showed lower spherical shaped osteocytes compared with other 
time points.  
Spherical shaped osteocytes were not at all significant at D10, D14, and D21. D28 showed 
significantly lower spherical shaped osteocytes when compared with D7 (p = 0.045), D10 
(p = 0.001), and D21 (p = 0.008).  
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Figure 12: Quantitative evaluation of osteocytes showed higher activity at D7 and lower 
activity at D28 during fracture healing. Silver nitrate stain was used to visualize and 
quantify morphological changes in osteocytes. Empty lacunae, spherical, and spindle 
shaped osteocytes were higher at D7 when compared with other time points. (A) 
Osteocytes were present in abundance around the fractured callus at D7. (B) Empty 
lacunae were significantly lower at D28 when compared with D10 and D21. (C) Spherical 
shaped osteocytes were significantly lower at D28 when compared with D7, D10, and 
D21. (D) Spindle shaped osteocytes were significantly lower at D28 when compared with 
D7 and D10. (N = 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 (D21, D28); Ot: osteocytes, 
Non-parametric distribution with Mann-Whitney U-test; * ≤ p = 0.05). 
Spindle shaped osteocytes count was higher at D7 compared with other time points (Figure 
12D). However, D28 showed lower spindle shaped osteocytes count compared with other 
time points. D10, D14, and D21 showed slight variation in spindle shaped osteocytes 
count with no significant differences (Figure 12D). D28 showed significantly lower 
spindle shaped osteocytes when compared with D7 (p = 0.045) and D10 (p = 0.002). 
Quantitative evaluation showed lower spindle shaped osteocytes with the progression of 
fracture healing. While, empty and spherical shaped osteocytes count declined from D7 
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until D14 followed by an increase at D21 and then again decline at D28. Further 
understanding of cellular changes within ECM during fracture healing process is required 
to understand the underlying molecular mechanism.   
4.11 Evaluation of MEPE and ERK during fracture healing showed 
negative correlation across time points  
Osteocytes express MEPE which regulates bone mineralization important for fracture 
healing. ERK is an ECM marker required for cell adhesion and migration. Therefore, 
MEPE and ERK immunohistochemistry were performed to understand the cellular 
changes within ECM during fracture healing (Figure 13 A, C). Furthermore, MEPE 
stained and ERK stained areas were quantified and then normalized to the total callus area 
(Figure 13 B, D). 
Descriptively, MEPE signal was seen in the fracture gap and in the periosteal region at D7. 
Furthermore, MEPE signal at D7 was also seen around bone marrow fat cells. MEPE 
signal was seen in proliferative chondrocytes and within bone marrow at D10. MEPE 
signal at D14 was seen within bone marrow and bone matrix (Figure 13A). MEPE signal 
at D21 was seen in osteocytes and within bone marrow. Furthermore, D28 showed MEPE 
signal within bone marrow surrounding fat cells. Histomorphometry showed higher MEPE 
stained area at D7 when compared with D10, D21, and D28 (Figure 13B). Furthermore, 
D10 showed higher MEPE stained area when compared with D21 and lower stained area 
when compared with D7, D14, and D28. MEPE stained area was higher at D14 when 
compared with other time points (Figure 13B). D21 showed lower MEPE stained area 
when compared with other time points. The positive stained area was higher at D28 
compared with D10 and D21 (Figure 13B). MEPE stained area was significantly lower at 
D10 compared with D28 (p = 0.038). 
Descriptively, ERK signal was seen around the callus border, in chondrocytes and within 
monocytes at D7. ERK signal at D10 was seen near proliferative chondrocytes and within 
bone marrow. D14 showed small patches of ERK signal in hypertrophy chondrocytes and 
bone marrow. Furthermore, ERK signal was seen within bone matrix and around fat cells 
present within bone marrow at D21 (Figure 13C). ERK signal was seen in bone matrix, 
bone marrow, and in close proximity of newly formed bone at D28.  
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Figure 13: Histological analysis of MEPE and ERK activity showed negative 
correlation across time points of healing. To understand the regulatory role of ECM in 
fracture healing, MEPE and ERK immunostaining were performed. (A) D14 showed 
MEPE stained region around the callus and mineralized matrix. (B) MEPE stained area 
was higher at D14 compared with other time points. D10 showed significantly lower 
MEPE area when compared with D28. (C) D21 showed ERK stained regions within the 
whole callus region. (D) ERK stained area was higher at D21 compared with other time 
points. D10 showed significantly lower ERK area when compared with D21 and D28.  (N 
= 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 (D21, D28); Non-parametric distribution with 
Mann-Whitney U-test; * ≤ p = 0.05). 
Histomorphometry showed higher ERK stained area at D7 when compared with D10 and 
D14 (Figure 13D). Furthermore, ERK stained area was lower at D10 when compared with 
other time points. D14 showed higher ERK stained area when compared with D10 (Figure 
13D). 
Interestingly, ERK stained area was higher at D21 when compared with other time points. 
D28 showed higher positive stained when compared with D7, D10, and D14 (Figure 13D). 
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Furthermore, ERK stained area was significantly lower at D10 when compared with D21 
(p = 0.038) and D28 (p = 0.009).  
Evaluation of MEPE and ERK signal intensity and localization during fracture healing 
process showed a well-balanced regulatory mechanism. Histomorphometry showed that 
ERK activity was lower in the region of higher MEPE activity and vice-versa. 
Furthermore bone mineralization and ECM regulation requires the continuous energy 
source during fracture healing. Therefore, further investigation of mitochondrial activity 
during fracture healing is required.  
4.12 High number of differentially expressed genes related to 
mitochondrial activity were present only at D3 and D7 
Demand of energy increases for cellular metabolism at the time of injury. Mitochondrion 
serve as an energy source inside a cell. Therefore, differentially expressed genes involved 
in mitochondrial activity were investigated. 
In total 39 mitochondrial genes were differentially expressed, 38 genes were 
downregulated and only 1 gene was upregulated (Table 5). 
Among downregulated genes were; Gpx1, Peroxidase 2 (Prdx2), and Peroxidase 3 (Prdx3) 
that play role against oxidative stress condition. Gpx1, Prdx2, and Prdx3 were significantly 
downregulated at D3 and D7. Furthermore, gene like 3-Oxoacid CoA transferase 1 
(Oxct1) which plays a central role in ketone body catabolism was significantly 
downregulated at D3 and D7. Energy production process requires transmembrane 
interaction and minerals transport. Genes like Solute carrier family 25 member 11 
(Slc25a11) and Solute Carrier Family 25 member 20 (Slc25a20) plays an important role in 
minerals transport and exchange through mitochondrial membrane. Furthermore, 
Branched chain ketoacid dehydrogenase kinase (Bckdk) plays a crucial role in 
transmembrane interaction with lipid bilayers. Slc25a11, Slc25a20, and Bckdk were 
significantly downregulated at D3 and D7. Other important genes for mitochondrial 
transport and electron transport chain are Transmembrane proteome 14C (Tmem14c), 
Atp5b, ATP synthase H+ transporting mitochondrial f1complex (Atp5f1), and Translocase 
of outer mitochondrial membrane 7 (Tomm7). Tmem14c, Atp5b, Atp5f1, and Tomm7 
were significantly downregulated at D3 and D7. Another source of energy production are 
Kreb’s cycle, respiratory chain, and TCA cycle within mitochondrion. Genes like Citrate 
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Synthase (Cs), Fumarate Hydratase 1 (Fh1), Succinyl CoA ligase (Suclg1), Ubiquinol-
Cytochrome C Reductase Core Protein 2 (Uqcrc2), and Cyc1 are important for above 
mentioned energy producing signaling pathways. Cs, Fh1, Suclg1, Uqcrc2, Cyc1 were 
significantly downregulated at D3 and D7. Coenzyme Q9 (Coq9) which involves lipid 
biosynthesis for electron transport chain was significantly downregulated at D3 and D7. 
Another downregulated genes was Cytochrome P450 family 27 subfamily A member 1 
(Cyp27a1) which plays a role in maintaining cholesterol homeostasis. Cyp27a1 was 
significantly downregulated at D3 and D7. Furthermore, there were erythropoiesis 
regulatory gene like Heat shock protein family a member 9 (Hspa9) and metal binding 
gene like Iron-Sulfur Cluster Assembly 1 (Isca1). Hspa9 and Isca1 were significantly 
downregulated at D3 and D7. Cold Shock domain containing protein E1 (Csde1) which 
acts as RNA binding protein during transcription and translation was significantly 
downregulated at D3 and D7. Further, glucose and fatty acid metabolism is important for 
bone homeostasis regulated by gene like Pyruvate Dehydrogenase Kinase 4 (Pdk4), which 
was significantly downregulated at D3 and D7. Another important gene is Electron 
transfer flavoprotein alpha subunit (Etfa) which is required for amino acid metabolism. 
Etfa was significantly downregulated at D3 and D7. Furthermore, Glutathione S 
transferase P1 (Gstp1) which links stress kinase and cell apoptotic pathway was 
significantly downregulated at D3 and D7. Another downregulated gene was Translocase 
of inner mitochondrial membrane 8 homolog B (Timm8b) which acts as chaperone for 
protein transport. Timm8b was significantly downregulated at D3 and D7. Genes like 
Vdac1 and Voltage Dependent Anion Channel 3 (Vdac3) that perform role in diffusion 
and binding of molecules were also downregulated. Vdac1 was significantly 
downregulated at D7 and Vdac3 was significantly downregulated at D3, D7, and D21. 
Furthermore, Carnitine O-palmitoyltransferase 1 (Cpt1b) which acts as a component for 
fatty acid beta oxidation was significantly downregulated at D10 and D14. Another 
downregulated genes were Cytochrome c oxidase subunit 8B (Cox8b), Cytochrome C 
oxidase subunit 7A1 (Cox7a1), and Cytochrome C oxidase subunit 6A2 (Cox6a2) that are 
involved in electron transport activity. Cox8b and Cox7a1 were significantly 
downregulated at D10 and D14. Cox6a2 was significantly downregulated at D10. Another 
important gene was Creatine kinase S-type (Cktm2) which serves as energy transducer 
was significantly downregulated from D3 through D7, D10 until D14. Furthermore, 
carbohydrate metabolism gene like Succinate dehydrogenase cytochrome b560 subunit 
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(Sdhc) was significantly downregulated at D14. Lyr motif containing protein 5 (Lyrm5) 
which acts as electron transfer flavoprotein regulator was significantly downregulated at 
D14. Another important gene was Dual Specificity Phosphatase 26 (Dusp26) which acts as 
an inhibitor of Mapk1 and Mapk3. Dusp26 was significantly downregulated at D14. Heme 
biosynthesis gene like Solute carrier family 25 member 37 (Slc25a37) was significantly 
downregulated at D21 and D28.Among upregulated genes, there was molecule exchange 
factor like Solute carrier family 25 member 5 (Slc25a5), which was significantly 
upregulated at D10. 
Highest number of differentially expressed genes related to mitochondrial activity were 
present at D3 and D7 compared with other time points. The results further showed the 
downregulation of genes involved in bone homeostasis and energy production. Further, 
histological evaluation of changes due to bone homeostasis during fracture healing is 
needed. 
Table 5: List of drastically downregulated mitochondrial genes and their FC and P-
value (white background: downregulated and grey background: upregulated)  
Gene D3 D7 D10 D14 D21 D28 
G
p
x
 1
 -2.95 -3.164     
7.9E-06 8.9E-06     
P
rd
x
2
 -3.235 -3.29    
 
1.80E-06 1.96E-06     
P
rd
x
3
 -2.429 -2.396    
 
6.92E-07 6.30E-06     
O
x
ct
1
 -3.157 -3.299     
2.92E-05 4.41E-05     
S
lc
2
5
a1
1
 
-2.06872 -2.1049     
2.56E-03 7.53E-05     
S
lc
2
5
a2
0
  -2.10498     
 2.86E-06     
B
ck
d
k
 -2.633 -2.198     
1.03E-05 7.8E-04    
 
T
m
em
1
4
c -2.46345 -2.075     
1.07E-05 1.5E-04    
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A
tp
5
b
 -2.64177 -2.618     
1.15 E-07 3.93E-07     
A
tp
5
f1
 -2.5096 -2.491     
2.22E-06 5.78E-04     
T
o
m
m
7
 
-2.322 -2.221     
1.25E-06 2.95E-06     
C
s 
-2.588 -2.573     
8.93E-05 5.75E-05     
F
h
1
 -2.907 -2.907     
6.72E-06 2.90E-06     
S
u
cl
g
1
 -2.205 -2.16     
1.87E-06 1.97E-05     
U
q
cr
c2
 -2.277 -2.278     
7.33E-06 6.90E-06    
 
C
y
c1
 -3.796 -3.73    
 
1.75E-06 3.08E-06     
C
o
q
9
 -3.328 -3.539     
1.06E-05 2.28E-07     
C
y
p
2
7
a1
 
-2.164 -2.303     
5.91E-06 2.05E-06     
H
sp
a9
 -2.499 -2.468     
1.1E-03 2.1E-04     
Is
ca
1
 -2.204 -2.368     
1.39E-06 3.89E-06     
C
sd
e1
 -3.414 -3.501     
3.15E-05 1.19E-04    
 
P
d
k
4
 -2.35 -2.255     
2.17E-05 1.43E-03     
E
tf
a 
-3.692 -3.623     
8.17E-05 1.36E-05     
G
st
p
1
 -2.566 -2.7103     
5.11E-05 1.76E-05    
 
T
im
m
8
b
 
-3.668 -3.866     
2.37E-05 6.14E-06     
V
d
ac
1
  -2.549     
 3.77E-06     
V
d
a
c3
 
-2.609 -2.732   -2.045  
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7.90E-04 9.26E-06   7.20E-03  
C
p
t1
b
   -2.445 -2.156   
  1.03E-05 3.40E-07   
C
o
x
8
b
   -2.514 -2.289   
  1.53E-06 3.19E-05   
C
o
x
7
a1
 
  -2.516 -2.491   
  1.76E-07 1.83E-05   
C
o
x
6
a2
 
  -2.436   
 
  1.86E-07    
C
k
m
t2
 -3.476 -3.454 -2.395 -2.112   
3.33E-07 7.87E-07 4.44E-07 7.73E-06   
S
d
h
c    -2.1253  
 
   6.59E-07   
L
y
rm
5
    -2.1653   
   1.15E-05   
D
u
sp
2
6
    -2.0079   
   4.45E-04   
S
lc
2
5
a3
7
     -2.4586 -2.684 
    1.42E-05 8.88E-06 
S
lc
2
5
a5
   2.109133    
  3.81E-06    
4.13 Evaluation of GPX1 immunohistochemistry showed higher positive 
signal at D28 
GPX1 is a mitochondrial gene which acts against oxidative stress to maintain bone 
homeostasis. Therefore, GPX1 immunohistochemistry was performed to investigate the 
changes during fracture healing process (Figure 14). GPX1 positive area normalized to 
callus area were evaluated from Toluidine Blue counter-stained sections (Figure 14 A, B). 
Furthermore, application of Silver Nitrate as counter-stain helped in investigating GPX1 
signal within osteocytes vicinity (Figure 14C). 
Descriptively in Toluidine Blue counter-stained slide, GPX1 signal was seen in small 
patches within bone marrow and in callus region at D7. Furthermore, D10 showed GPX1 
signal in proliferative chondrocytes, bone marrow, and bone lining cells. GPX1 signal at 
D14 was seen within bone marrow and bone matrix. Furthermore, D21 and D28 showed 
higher GPX1 signal within bone matrix and around fat cells present within bone marrow. 
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Furthermore, GPX1 signal at D28 was also seen near the newly formed bone (Figure 
14A). 
Histomorphometry showed lower GPX1 positive area at D7 when compared with other 
time points (Figure 14B). D10 showed higher GPX1 positive area when compared with D7 
but lower GPX1 positive area when compared with D14, D21, and D28. GPX1 positive 
area was higher at D14 when compared with D7, D10, and D21 (Figure 14B). 
Furthermore, GPX1 area was higher at D21 when compared with D7 and D10. D28 
showed higher GPX1 stained area when compared with other time points (Figure 14B). 
But no significant differences were observed. 
Descriptively, Silver Nitrate counter-stained sections showed GPX1 signal within 
osteocytes and around blood vessels (Figure 14C). GPX1 signal was seen around blood 
vessels rather than osteocytes at D7. Further, GPX1 positive signal was seen around blood 
vessels and some patches within osteocytes vicinity at D10. Interestingly, D14 showed 
higher number of GPX1 signal within osteocytes vicinity than blood vessels (Figure 14C). 
GPX1 signal was seen in osteocytes vicinity and around blood vessels at D21. GPX1 
signal was not seen within osteocytes at D28. 
Evaluation of GPX1 signal during fracture healing showed higher signal with progression 
of fracture healing. Furthermore, D14 and D21 showed higher GPX1 signal within 
osteocytes compared with other time points. Further analysis is needed to investigate the 
effect of oxidative stress on protein synthesis activity. 
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Figure 14: Histological analysis of GPX1 activity during fracture healing showed active 
positive signal around blood vessels and osteocytes vicinity. To understand the changes in 
anti-oxidant activity, GPX1 immunostaining were performed. Toluidine Blue and Silver 
Nitrate counter-stains were used to investigate overall and osteocyte-specific GPX1 
positive signal, respectively. (A) D28 showed GPX1 stained region around the newly 
formed bone and bone marrow. (B) GPX1 stained area was higher at D28 compared with 
other time points. (C) Active osteocyte signals visualized via Silver Nitrate counter-stain 
within GPX1 positive areas. (N = 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 (D21, D28), 
Ot: osteocytes). 
 
4.14 High number of differentially expressed genes related to ribosomal 
activity were present only at D3 and D7 
The ribosome plays a key role in protein synthesis which further relies on mitochondrion 
for energy production. Therefore, differentially expressed genes involved in ribosomal 
activity were investigated. 
In total 15 ribosomal genes were differentially expressed, 13 genes were downregulated 
and 2 genes were upregulated (Table 6). 
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Among downregulated genes, there were cell differentiation and proliferation markers like 
Rps6, Ribosomal protein L24 (Rpl24), Ribosomal protein L27 (Rpl27), Ribosomal protein 
L31 (Rpl31), Rps2, and Ribosomal protein L36a like (Rpl36al). Interestingly, Rps6, 
Rpl24, Rpl27, Rpl31, Rps2, and Rpl36a1 were significantly downregulated at D3 and D7. 
Another important gene was Ubb which regulates cell cycle via proteasome complex 
crucial for cell survival. Ubb was significantly downregulated at D3 and D7. Furthermore, 
Mrpl53 which plays role in erythrocyte differentiation was significantly downregulated at 
D3 and D7. Another downregulated genes were ribosomal structural constituent like 
Mitochondrial ribosomal protein L33 (Mrpl33) and ribosomal biogenesis gene like 
Nucleophosmin 1 (Npm1). Mrpl33 was significantly downregulated at D3. While, Npm1 
was significantly downregulated at D3 and D7. Gene like Methionyl aminopeptidase 1 
(Metap1) which plays role in protein maturation was significantly downregulated at D7. 
Furthermore, E2F transcription factor 2 (E2f2) which controls cell cycle progression was 
significantly downregulated at D21 and D28. Another downregulated gene was 
Heterogeneous Nuclear Ribonucleoprotein H1 (Hnrnph1) which plays an important role in 
RNA splicing. Hnrnph1 was significantly downregulated at D3, D7, D21, and D28.  
Among upregulated genes, there were Metallothionein 3 (Mt3) which encodes ion 
homeostasis and Protein disulfide isomerase family a member 3 (Pdia3) which encodes 
endoplasmic reticulum. Mt3 was significantly upregulated at D10, D14, and D21. While, 
Pdia3 was significantly upregulated at D10. 
High number of ribosomal genes were significantly expressed at D3 and D7 when 
compared to other time points. 
Table 6: List of differentially expressed ribosomal genes and their FC and P-value 
(white background: downregulated and grey background: upregulated)  
 
Gene D3 D7 D10 D14 D21 D28 
R
p
s6
 -3.925 -3.542     
3.40E-05 7.50E-04     
R
p
l2
4
 
-3.0135 -2.987 
    
5.92E-05 3.45E-05 
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R
p
l2
7
 -2.704 -2.7882     
2.35E-07 5.13E-06     
R
p
l3
1
 -4.360 -3.889  
   
5.82E-06 1.54E-05  
   
R
p
s2
 
-4.3006 -4.174     
5.25E-05 1.72E-07     
R
p
l3
6
al
 
-2.352 -2.328 
    
1.55E-06 2.62E-05 
    
U
b
b
 -3.837 -3.823     
5.82E-08 3.13E-06     
M
rp
l5
3
 -2.1221 -2.8511     
3.84E-06 1.10E-03     
M
rp
l3
3
 -2.035      
1.41E-05      
N
p
m
1
 -2.5708 -2.758 
    
1.12E-05 5.11E-05     
M
et
ap
1
  -2.02905     
 1.13E-03     
E
2
f2
 
    -2.040 -2.350 
    9.61E-05 2.00E-03 
H
n
rn
p
h
1
 
-2.261 -2.319   -2.053 -2.003 
1.92E-06 1.49E-05   2.82E-06 1.20E-04 
M
t3
   2.1711 2.177 2.2716 
 
  2.90E-03 3.19E-03 2.54E-03 
 
P
d
ia
3
   2.083    
  3.82E-06    
 
The results showed the downregulation of genes involved in bone synthesis and cell cycle 
regulation. Furthermore, histological evaluation of changes during fracture healing due to 
cell cycle regulation is needed. 
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4.15 Evaluation of UBB immunohistochemistry showed higher positive 
signal at D7 
UBB is a conserved proteasome complex which regulates cell cycle and Nuclear factor 
Kappa-light-chain-enhancer of activated B cells (NF-κB) signaling. Therefore, UBB 
immunohistochemistry was performed to understand the changes during fracture healing 
process (Figure 15). UBB positive area normalized to callus area were evaluated from 
Toluidine Blue counter-stained sections (Figure 15 A, B). Furthermore, application of 
Silver Nitrate as counter-stain helped in investigating the UBB signal within osteocytes 
vicinity. 
Descriptively in Toluidine Blue counter-stained sections, UBB signal was seen in 
chondrocytes, callus border, and bone marrow at D7 (Figure 15A). Further, UBB signal at 
D10 was seen in the proliferative chondrocytes and endosteum region. Interestingly, both 
D14 and D21 showed UBB signal within bone marrow and mineralized callus region. 
UBB signal was seen within bone marrow and in newly formed bone at D28. 
Histomorphometry showed higher UBB stained area at D7 when compared with other time 
points (Figure 15B). D10 showed higher UBB stained area when compared with D14, 
D21, and D28. UBB stained area was higher at D14 when compared with D21 and D28 
(Figure 15B). UBB stained area at D21 was lower when compared with other time points. 
Furthermore, UBB stained area was higher at D28 when compared with D21 (Figure 15B). 
UBB stained area was significantly higher at D7 when compared with D21 (p = 0.003) and 
D28 (p = 0.006). Furthermore, D10 showed significantly higher UBB stained area when 
compared with D21 (p = 0.040). D14 showed significantly higher UBB stained area 
compared with D21 (p = 0.017).  
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Figure 15: Histological analysis of UBB activity during fracture healing showed active 
positive signal around blood vessels. To understand the changes in ribosomal activity, 
UBB immunostaining was performed. Toluidine Blue and Silver Nitrate counter-stains 
were used to investigate overall and osteocyte-specific UBB positive signal, respectively. 
(A) D7 showed UBB stained region near to periosteal region and bone marrow. (B) UBB 
stained area was significantly higher at D7, D10, and D14 when compared with D21. 
Furthermore, D7 showed significantly higher UBB stained area compared with D28. (C) 
Positive signal of UBB visualized around blood vessels in the fractured callus via Silver 
Nitrate counter-stain. (BV: blood vessel; N = 4 (D7), N = 6 (D10), N = 3 (D14), N = 5 
(D21, D28), *= p ≤ 0.05, Non-parametric distribution: Mann Whitney U-test). 
Descriptively, UBB counter-stained with Silver Nitrate showed positive signal around 
blood vessels than osteocytes (Figure 15C). UBB signal was prominent around blood 
vessels at D7. While, UBB signal at D10 was lower around blood vessels compared with 
D7. Furthermore, UBB signal at D14 around blood vessels increased compared to D10. 
While, D21 and D28 showed comparatively very less positive signal around blood vessels. 
No osteocytes positive signal was seen at any time point of healing. 
Evaluation of UBB signal showed a wave like pattern with a decline from D7 to D14 and 
then an increase until D28. Ribosomal proteins plays important role in different signaling 
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like immune system and cell development. Further understanding of fracture healing relies 
on the examination of differentially expressed genes involved in immune system. 
4.16 High number of differentially expressed genes related to immune 
response were present only at D10 
Fracture healing process initiates with pro-inflammatory reaction that triggers healing 
events. Immune system plays a key role in providing defense mechanism at the time of 
injury. Therefore, differentially expressed genes involved in immune response were 
investigated. 
In total 15 immune response genes were differentially expressed, 5 genes were 
downregulated and 9 genes were upregulated (Table 7). Gene like beta 2 microglobulin 
(B2m) which is part of adaptive immune response was significantly downregulated at D3 
and D7 while significantly upregulated at D10. 
Among downregulated genes, there were innate immune response genes like S100 
Calcium Binding Protein A8 (S100a8) which induces neutrophil chemotaxis was 
significantly downregulated at D3, D7 and Radical S-Adenosyl Methionine Domain 
Containing 2 (Rsad2) which prevents virus infection was significantly downregulated at 
D21 and D28. Another important gene was Interleukin 11 receptor subunit alpha 1 
(Il11ra1) which helps in cell proliferation. Il11ra1 was significantly downregulated at D10. 
Synuclein alpha (Snca) which serves in membrane trafficking was significantly 
downregulated at D10, D21, and D28. Gene like Adenosine monophosphate deaminase 1 
(Ampd1) which encodes for adaptive immune response, specifically T cells was 
significantly downregulated at D7, D10, and D14.  
Among upregulated genes, there were innate immune response genes like Cathepsin G 
(Ctsg), Lipocalin 2 (Lcn2), and Peptidoglycan recognition protein 1 (Pglyrp1) that provide 
defense against pathogens. Ctsg, Lcn2, and Pglyrp1 were significantly upregulated at D10 
and D14. Fc fragment of IgE Receptor 1g (Fcer1g) which performs collagen mediated 
platelet and neutrophil activation was significantly upregulated at D10 and D14. Another 
important gene is Interferon induced transmembrane protein 2 (Ifitm2) which inhibits virus 
entry to cytosol. Ifitm2 was significantly upregulated at D10. Another innate immune 
response gene is Ficolin B (Fcnb) which plays a role in lectin complement pathway 
activation to protect against micro-organisms. Fcnb was significantly upregulated at D10. 
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Furthermore, NF-kB signaling plays an important role in cytokine production and cell-
survival. Gene like Secretory Leukocyte Peptidase Inhibitor (Slpi) which plays role in 
regulating NF-Kb signaling was significantly upregulated at D10. Natural killer cells and 
T cells express perforin (Prf) to target cell membranes. Prf1 was significantly upregulated 
only at D7. Gene like Placenta specific 8 (Plac8) encodes for adaptive immune response, 
specifically B cells. Plac8 was significantly upregulated at D10 and D14.  
Table 7: List of differentially expressed immune response genes and their FC and P-
value (white background: downregulated and grey background: upregulated) 
Gene D3 D7 D10 D14 D21 D28 
S
1
0
0
a8
 -4.5539 -4.54909     
5.83E-06 5.16E-06     
R
sa
d
2
     -2.7446 -2.333 
    1.45E-06 7.18E-06 
Il
1
1
ra
1
   -2.3639    
  3.09E-06    
S
n
ca
   -2.182  -3.173 -3.102 
  7.69E-06  2.38E-06 1.46E-05 
B
2
m
 -3.156 -3.394 2.04    
1.63E-04 4.56E-07 2.49E-05    
A
m
p
d
1
   -2.3216 -2.5181   
  1.88E-05 3.83E-06   
C
ts
g
   2.769 2.342   
  2.01E-05 2.32E-05   
L
cn
2
 
  4.061 3.698   
  1.56E-06 2.76E-06   
P
g
ly
rp
1
 
  2.73 2.361   
  3.78E-04 7.2E-04   
F
ce
r1
g
   2.316 2.598   
  9.37E-06 1.81E-06   
If
it
m
2
   2.008    
  3.87E-05    
F
cn
b
 
  2.521    
  1.13E-05    
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S
lp
i 
  2.3009    
  1.16E-05    
P
rf
1
  2.0429     
 1.35E-04     
P
la
c8
   3.0235 2.3921   
  1.49E-04 9.89E-04   
 
Higher number of genes were differentially expressed at D10 and D14 when compared 
with other time points. Differentially expressed genes involved in immune response are 
involved in cell survival and metabolism related signaling pathways. Therefore, a better 
understanding of cross-talk between immune response and bone metabolism is required to 
unravel complexity of fracture healing. 
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5. DISCUSSION 
Fracture healing involves well-coordinated molecular and cellular overlapping events with 
distinct histological characteristics [88]. The overlapping events of healing involve: 1) an 
early inflammatory response, 2) formation of soft callus, 3) hard callus formation, 4) bony 
bridging, and 5) bone remodeling [89]. However, 10 to 15% of fractures fail to reach bony 
consolidation resulting in a non-union or delayed healing [90]. Cellular deformities and 
genetic change leads to severe skeletal disorders like osteogenesis imperfecta [91] and 
neurofibromatosis type 1 [92].  
This study investigates cellular and molecular changes during femoral fracture healing in a 
wild type male mice model. The research aims at understanding the differentially 
expressed genes in the fracture healing. Further, common genes in the overlapping healing 
events were also focus of this study. The current study focused on unraveling the role of 
six highly enriched biological processes: angiogenesis, ossification, ECM regulation, 
immune response, mitochondrial, and ribosomal activity in fracture healing. This 
understanding of overlapping healing events and enriched biological processes shall reflect 
on the translational potential to treat cases of delayed healing, non-union, and skeletal 
disorders. 
Prior to detailed analysis, this study examined the validity of different FC cut-off criteria 
along with lower P-value to test the discrepancies in microarray data interpretation. The 
comparison of FC cut-off showed decline in gene numbers, whereas the highly enriched 
biological processes stayed at all cut-offs. Further, the comparison of DEG in every two 
consecutive time points provided an insight to the overlapping healing events. Hierarchical 
clustering based on expression profile across time points provided an overview of 
differential expression during fracture healing. This study showed presence of overlapping 
genes between enriched biological processes suggesting possible cross-talk during fracture 
healing. Quantitative evaluation of collagen fibril arrangement were carried out using CT-
FIRE plugin in this study. The transition from woven bone to lamellar bone structure were 
evident during fracture healing. Further, type I collagen ring like structure was seen around 
osteocytes at all investigated time points. On the cellular level, MEPE and ERK evaluation 
showed a feedback mechanism with the progression of fracture healing. This study, 
described for the first time, -to my knowledge- differential expression of mitochondrial 
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and ribosomal genes in fracture healing. Further, immunostaining of mitochondrial protein 
GPX1 and ribosomal protein UBB were carried out to validate the differential expression.  
Microarray data analysis and histological analysis altogether provided a building block of 
successful fracture healing.  
5.1 Fold change cut-off and data interpretation 
Microarray technology enables identification of biomarkers to diagnose diseases [93, 94]. 
FC and P-value cut-off criteria is usually applied to obtain DEGs in microarray data 
analysis. The choice of FC and P-value cut-off relies on the biological question. Many 
studies used FC cut-off of |0.5|, |1|, or |2| and P-value ≤ 0.05 to obtain DEG in different 
fracture healing animal models [4, 5, 95, 96]. Dalman MR et al. 2012 reported the 
discrepancies in data interpretation with change in FC cut-off in zebrafish microarray data 
[97]. Therefore, this study tested whether changing FC cut-off results in misinterpretation 
of microarray data. 
The obvious decline in number of DEG with increasing FC cut-off were seen in this study. 
This loss of genes with increasing cut-off reflected on gene ontology pattern (Figure 5). 
Nonetheless, the highly representative processes were present at all FC criteria’s despite 
the decline in gene numbers. Genes involved in processes like angiogenesis, ossification, 
ECM regulation, and immune response with known role in fracture healing were detected 
at all FC cut-offs. Intriguingly, genes involved in processes like mitochondrial and 
ribosomal activity with undefined role in bone healing were also present at all cutoffs in 
similar or close ratios. 
Angiogenesis is essential for bone regeneration and also used as a possible therapeutic 
approach to enhance bone regeneration [98]. This study showed the lower percentage of 
upregulated angiogenesis related genes when compared with ossification, ECM regulation, 
and immune response (Figure 5). The lower percentage of angiogenesis points to the 
crucial role of some genes over the others for successful healing. 
Ossification and ECM regulation are interdependent processes essential for bone 
homeostasis [99]. This study showed the higher percentage of upregulated ossification and 
ECM genes with increasing FC cut-off (Figure 5 A, C, E). The increased percentage points 
to the presence of higher number of DEG with FC ≥ |2| involved in ossification and/or 
ECM regulation in this study. Immune response were present in higher percentage at FC ≥ 
60 
 
1 and FC ≥ 1.5, however at FC ≥ 2, immune response were present in equal percentage as 
ossification and ECM in upregulated pattern (Figure 5C). This directs towards the equal 
need and importance of ossification, ECM, and immune response for successful fracture 
healing.  
Ribosomal proteins are important for protein synthesis which serve for metabolic 
activities. This study showed lower percentage of ribosomal genes at all FC cut-off in both 
up- and down-regulated panels (Figure 5). The importance of ribosomal proteins in 
fracture healing is not known in fracture healing as per my knowledge. However, the 
percentage contribution of ribosomal genes at all FC cut-offs in this study points to an 
essential role to infer the underlying molecular mechanism. 
Mitochondrial activity plays a fundamental role in energy production, cell signaling, 
apoptosis, and homeostasis [100]. However, little is known about the exact role of 
mitochondrial genes in fracture healing. In this study, the presence of mitochondrial 
activity in highest percentage among downregulated panel at all FC cut-offs reflects on its 
importance and need during fracture healing (Figure 5 B, D, F). 
Collectively, this study showed the consistent presence of highly represented biological 
processes despite the change in FC cut-off and percentage distribution. This study reported 
the importance of FC cut-off comparison as pre-requisite for microarray data analysis to 
correctly investigate the underlying molecular mechanism. The comparison of FC cutoffs 
showed that the highly altered genes during fracture healing remained as well at higher 
cut-off. Therefore, detailed analysis were carried out using cut-off of FC = |2| and P-value 
≤ 0.01.  
5.2 Fracture healing: series of overlapping events 
Fracture healing process is divided into five overlapping events, each characterized by 
specific cellular and molecular activity [89]. However, a clear delineation of each healing 
event is missing because of experimental limitations. The approach to find the beginning 
and end of each healing event is to sacrifice animals at each consecutive time points from 
D0 until D28. However, such experimental design is impractical due to animal ethics and 
costs involved. This study compared DEG present between every two consecutive time 
points to identify overlapping genes crucial for fracture healing. Further, gene ontology of 
61 
 
overlapping genes provided an insight to the pattern of highly representative biological 
processes (Figure 6). 
This study showed the highest percentage of mitochondrial genes in the overlap between 
D3 and D7 (Figure 6). Mitochondrial proteins carry out energy production which is more 
important at the time of injury. Leung KS et al. 1989 reported higher adenosine 
triphosphate (ATP) content within fractured callus of 12 week old rabbits during the early 
phase of healing [101]. This study suggests that the presence of mitochondrial genes 
during inflammatory phase is important for successful bone regeneration.  
Highest percentage of ECM genes in the overlap between D7 & D10, D10 & D14, and 
D14 & D21 were seen in this study. This points to the central role of ECM during 
endochondral ossification and primary bone formation. Horton WA et al. 1988 showed 
that ECM serve as a scaffold during the transition from cartilage to bone in endochondral 
ossification phase in humans [102]. The continuous highest percentage of ECM genes in 
this study points to the regulatory role of ECM in transition from one to another healing 
event (Figure 6B). 
Highest percentage of genes related to immune response were detected in the overlap 
between D21 and D28 (Figure 6). Immune response is very important against infection 
and inflammation, which can result in delayed healing. The highest percentage of immune 
response in this study during late phase of healing directs towards prevention of any 
inflammatory response. Raggatt LJ et al. 2010 reported the importance of innate and 
adaptive immune response in balanced bone remodeling process [103].  
Taken together, comparison of DEG in consecutive time points helped in inferring 
overlapping genes important for fracture healing. Further, gene ontology provided an 
insight to crucial biological processes across overlapping time points. These results 
provided a better understanding to the overlapping healing events. To my knowledge, no 
previous study has evaluated the number and role of overlapping genes in the healing 
stages. 
5.3 Hierarchical clustering method 
Alignment of genes based on expression profile provides a global overview of 
upregulation and downregulation pattern. This study utilized hierarchical clustering 
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method which resulted in ten distinct clusters. Gene ontology of genes from each cluster 
provided a general picture of important biological process for bone healing (Figure 7). 
Genes involved in same biological process like mitochondrial activity were aligned in 
more than one cluster (Figure 7). The presence of mitochondrial genes in different clusters 
directs to the varied expression profile during fracture healing. Similar alignment were 
seen with ECM genes, ossification, immune response, and ribosomal proteins in this study. 
Intriguingly, only angiogenesis genes were present in a single cluster, which directs 
toward similar expression profile across time points. Mitochondrial activity and ECM 
regulation were the highly enriched biological processes seen in this study. 
Mitochondrial enzymes like Oxct1 which plays a role in ketone body catabolism [104] 
were differentially expressed in this study. Other mitochondrial genes like Gpx1 which 
acts against oxidative stress [105] were differentially expressed in this study.  
ECM genes were present in four distinct clusters (Figure 7). Further, this study showed the 
presence of ECM, immune response / angiogenesis, and bone mineralization in the same 
cluster. This points to the cross-talk between biological processes and multi-functional role 
of genes during fracture healing. Genes like Ibsp and Mgp, that are part of ECM and 
important for bone mineralization [106] were present in this study. Further, Mmp13 gene 
which plays a role in ECM organization, bone mineralization, and angiogenesis [107] was 
present in one cluster.  
Taken together, hierarchical clustering followed by gene ontology connected temporal 
expression profile of DEG with highly enriched biological processes.  
5.4 Angiogenesis 
Blood supply is an essential need for normal fracture healing [108]. Hematoma formed at 
the site of injury serve as template for blood vessel development. Incomplete 
vascularization results in delayed healing or cases of non-union [98].  
ASMA immunostaining used in this study helped in blood vessel visualization (Figure 8). 
Higher ASMA stained area and higher blood vessel count were seen at D7 in the fractured 
callus region (Figure 8). The higher blood vessel count points towards the increased 
cellular activity and mineral transport in early phase. Further, the blood vessels count were 
lower at D21 and higher at D28 suggesting potential involvement in bone remodeling 
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phase. McDonald SJ et al. 2012 reported that the higher gene expression of Asma at D7 
post-fracture promote fracture healing via callus contraction in rat fractured callus [109]. 
Kinner B et al. 2002 reported that smooth muscle actin containing cells enables contractile 
motion required for bony bridging in murine model [110]. Saran U et al. 2014 showed that 
vascularization is prerequisite for ossification and new blood vessels provides the medium 
to osteoprogenitor cells for bone formation [111]. The transitional change in blood vessels 
count with fracture healing progression as seen in this study suggests a possible cross-talk 
between vascularization and bone formation process (Figure 8).  
Growth factors and cytokines work together at molecular level to carry out successful 
angiogenesis. The compromised blood supply at the time of injury and oxygen deprivation 
results in hypoxic condition. Under the hypoxic condition, the anti-oxidant enzymes plays 
an important role to establish bone homeostasis and prevent oxidative damage. An anti-
oxidant enzyme; Gpx1 was significantly downregulated only at D3 and D7 in this study. 
The differential expression of Gpx1 during inflammatory phase of healing points to its 
importance to overcome hypoxic situation. Lubos E et al. 2011 showed that Gpx1 reduces 
ROS (hydrogen peroxide) to water, by preventing cellular damage [32]. Intriguingly, 
previous reports also showed that ROS is essential for embryonic stem cell differentiation 
in a murine model [112]. Further, differentiation of embryonic stem cells results in 
endothelial cells that are crucial for vasculogenesis [113]. The downregulation of Gpx1 in 
this study directs towards increased ROS, which leads to stem cell differentiation into 
endothelial cells.  
Hypoxic condition further induces the activation of pro-angiogenic factor like Vegfa, 
which is required for endothelial cell migration and proliferation [114]. Vegfa was 
significantly downregulated at D3 and D7 in this study. The differential expression of 
Vegfa during inflammatory phase suggests the possible role in promoting angiogenesis. 
However, Vegfa is also a key mediator of angiogenesis in cancer, where it influence the 
production of tumor vasculature for nutrients exchange [115]. Therefore, an excess of 
Vegfa expression can result in pathological condition. Hoeben A et al. 2004 showed that 
Vegfa induce angiogenesis via endothelial cell proliferation and migration [114]. The 
migration of endothelial precursor cells to form new blood vessels during embryonic 
development is regulated by the activity of angiogenic and anti-angiogenic factors [116]. 
The differential expression of Serpinf1, an anti-angiogenic factor, was detected at D3 and 
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D7 in this study. The downregulation of Vegfa and an upregulation of Serpinf1 points to 
the regulatory interaction during angiogenesis. Venturi G et al. 2012 showed that Serpinf1 
is essential for the differentiation of osteoprogenitor cells required for fracture healing 
[117]. They also showed the antagonist potential of Serpinf1 to Vegfa in regulating bone 
formation and resorption. The current study showed that successful fracture healing took 
place when Vegfa was downregulated and Serpinf1 was upregulated. Intriguingly, Homan 
EP et al. 2011 reported the loss of Serpinf1 in the pathology of osteogenesis imperfecta 
type VI [118]. The upregulation of Serpinf1 during inflammatory phase in this study 
further suggests its therapeutic potential to treat angiogenesis related diseases and rare 
bone diseases.   
The success of angiogenesis relies on ECM proteins as well besides angiogenic and anti-
angiogenic factors [98]. MMP family proteins regulates Vegfa and degrade bone matrix, 
thereby promoting angiogenesis. Mmp2 gene which is important for ECM degradation 
was downregulated at D3 and D7 in this study. The differential expression of Mmp2 
during inflammatory phase suggests that Mmp2 degrade old bone matrix to make space for 
new blood vessel formation. Stetler-Stevenson WG. 1999 showed that Mmp2 promote 
endothelial cell invasion by selectively degrading ECM to promote angiogenesis [119]. 
Other Mmp family gene; Mmp9 was significantly upregulated in this study at D10, D14, 
and D21. Mmp9 expression in this study points to the role in the overlapping of 
inflammatory and ossification phase. Colonot C et al. 2003 reported the generation of large 
cartilaginous callus and delayed vascularization in a knock-out mice model of Mmp9-/- 
[120]. 
Blood vessel integrity is crucial for the success of fracture healing. Transforming growth 
factors family proteins play an important role in establishment and maintenance of blood 
vessel integrity [121]. Tgfbr1 and Tgfbr2 were upregulated in this study at D14 and D10, 
respectively. This points to the importance of Tgfbr1 and Tgfbr2 in the overlapping region 
of angiogenesis and ossification. Larsson J et al. 2001 reported the early death of mice 
lacking Tgfbr1 because of vascularization defect [122]. Further, weakened cell migration 
and differentiation properties in endothelial cells were seen in Tgfbr1 deficient mice. Wu 
M et al. 2016 also showed defective vascularization due to lack of Tgfbr2 in mice, that 
further resulted in rheumatoid arthritis [22]. Nonetheless, overproduction of either Tgfbr1 
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or Tgfbr2 can result in fibrosis related disorders [123, 124]. Therefore, a balanced gene 
expression of Tgfbr1 and Tgfbr2 is essential to prevent any complication during healing.  
Taken together, differential expression analysis showed the interdependence of different 
growth factors, ECM proteins, and cytokines in successful blood vessel formation. The 
altered regulation in angiogenesis process can result in delayed healing. Further, the results 
showed an insight to the pathological condition that might occur due to lower or higher 
expression of genes. The cross talk between different proteins further suggests the 
overlapping transition from angiogenesis process to ossification phase. 
5.5 Ossification 
Soft cartilaginous callus formed around the fracture gap serves as a route for cellular 
activity and ECM deposition, which is important in fracture healing [125]. Chondrocytes 
gathers in the fractured callus and proliferate, thereby initiating bone matrix synthesis 
(Figure 9 A, B). Chondrocytes proliferate until all fibrous tissue is replaced by cartilage 
[126, 127]. Chondrocytes undergo hypertrophy to mineralize the cartilaginous matrix and 
once the mineralized matrix is formed, chondrocytes apoptosis takes place [128]. The 
mineralization of callus started from periosteal region by D10 post-fracture and 
mineralized bone matrix area increased at D14 (Figure 9 B, C). The hard callus formation 
progresses with mineralization of cortices at D21, by providing mechanical stability 
(Figure 9D). However, the hard callus formed is typically woven bone and not 
mechanically stable as normal bone [89]. Therefore, bone remodeling takes place to form 
regular lamellar bone by balanced osteoblasts and osteoclasts activity [70]. Bone 
remodeling phase resulted in complete mineralization of bone matrix with bony bridging 
by D28 (Figure 9E).  
Well-coordinated molecular signals are required for ossification to result in bone 
mineralization and bony bridging. Cell differentiation and degradation of old bone matrix 
takes place to build new bone. Ubiquitin proteasome complex controls cell differentiation 
and degradation of intracellular proteins [129]. Ubb, which encodes ubiquitin was 
downregulated in this study at D3 and D7. Ubb differential expression during 
inflammatory phase suggests its role in degradation of proteins. Schundt C et al. 2015 
reported the upregulation of Ubb in macrophage depleted mouse model which showed 
defective ossification [130]. Uyama M et al. 2012 also reported the negative in-vitro 
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correlation between Ubb expression and osteoblast formation [131]. This indicates that 
Ubb downregulation inversely affects the ossification and osteoblast activity.  
Osteoblasts initiate matrix mineralization via different factors like Ibsp, Mmp9, Mmp13, 
and collagen family proteins. Ibsp and Mmp13 were significantly upregulated in this study 
at D3, D7, D10, D14, and D21. The continuous differential expression of Ibsp and Mmp13 
directs to their importance in soft callus and hard callus formation. Malaval L et al. 2008 
reported undermined bone growth and mineralization in Ibsp depleted mouse model [132]. 
Inada M et al. 2004 reported the delay in endochondral ossification and early 
vascularization in Mmp13-null mice [133]. Another member of Mmp family; Mmp9 was 
upregulated in this study at D10, D14, and D21. The presence of both Mmp13 and Mmp9 
at D10, D14, and D21 points to a combined role in ossification. Ortega N et al. 2009 
reported that Mmp9 is important for invasion of osteoclasts and endothelial cells into 
hypertrophic cartilage whereas Mmp13 is important for bone formation [99]. Rodenberg E 
et al. 2011 reported the onset of heterotopic ossification due to early expression of Mmp9 
post-fracture in murine model [134]. This points to the fact that aberrant expression of 
Mmp9 can lead to ossification related pathologies. 
Collagen family proteins are the richest protein in human body and type I collagen is the 
most generous form of collagen in ECM [135]. Collagen family proteins (Col10a1, 
Col1a1, and Col2a1) were significantly upregulated in this study. This reflects on the 
mineralized matrix formation.  
Collectively, this study showed the differential expression of ossification related genes 
mainly during intermediate phases of healing. Further, the successful ossification relies on 
balanced collagenous as well as non-collagenous proteins expression. Any dysregulation 
in ossification gene expression can result in defective mineralization and therefore affect 
the bone quality. 
5.6 Extracellular matrix 
ECM is a network of macromolecules that control cell proliferation, survival, 
differentiation, and mineralization [136]. ECM is one of the key player in maintenance of 
bone integrity [137]. The main fibrous component of ECM is collagen, which is essential 
for biomechanical competence and integrity [138]. This study utilized Sirius red stain to 
investigate the changes in collagen fiber arrangement with healing progression (Figure 10, 
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11). Type I collagen were irregularly arranged at D7 post-fracture and later arranged in 
well-organized sheets by D28. The formation of organized collagen at the late phase of 
healing points to the stability of newly formed bone. Bigham-Sadegh A et al. 2015 
reported the randomly arranged collagen fibers during woven bone formation while 
organized and parallel sheet after lamellar bone formation [139]. Further, significant 
upregulated expression of Col1a1 at D7, D10, D14 and Collagen type 1 alpha 2 (Col1a2) 
at D3 until D14 were seen in this study. This reflects on the importance of collagens 
proteins in ECM organization. Gajko-Galicka A. 2002 showed that the reduction in type I 
and type II collagen results in osteogenesis imperfecta, characterized by bone fragility and 
structural deformities [140]. This indicates the prime importance of collagens in 
maintenance of structural integrity.  
Quantitative evaluation of collagen fibrils orientation provides a further insight to ECM 
organization. This study implemented CT-FIRE plug-in for the first time on monochrome 
10X images taken from polarized filter (Figure 4, 11). The above mentioned plug-in was 
adapted previously for quantitative evaluation of fibril structure obtained from TEM and 
fluorescence microscopy [83, 141]. Fiber angle points to the bone quality via fibril 
alignment. Higher Fiber angle was detected in this study at D28 (Figure 11C). The higher 
angle indicates the higher bone stiffness. Vincentelli R et al. 1971 reported the influence of 
mechanical factors on collagen fiber orientation [142]. They noticed lower angle of 
orientation in older people and higher angle of orientation in young people. This might be 
due to the organization of bone matrix and lower cellular activity in older patients. Fiber 
length affects the mechanical and structural properties of bone. The higher fiber length at 
D28 points to the mechanical stability of bone (Figure 11D). Hanley CJ et al. 2016 
reported the accumulation of smaller fibers in patients with multiple tumor [143]. Daghma 
DES et al. 2017 also reported the higher frequency of small fibers in osteoporotic rat 
model [83]. This shows that deviation of fiber length can result in pathological conditions. 
Evaluation of fiber width helps in investigation of collagen fibers networking. Fiber width 
was higher in this study at D28 (Figure 11E). This might be because of compact and cross-
linked structure formed after bone remodeling. Kim CL et al. 2016 reported the impact of 
fiber thickness on compact or rough nature of collagen fibers [144]. Fiber straightness 
marks the anisotropic or isotropic nature of fibers (Figure 11F). Collagen fibers showed 
anisotropic nature in this study at all time points. Further, differential gene expression of 
other collagenous proteins besides type I and type II were detected in this study. Non-
68 
 
collagenous proteins like Ibsp and Spp1 were also significantly upregulated in this study. 
The differential expression of collagenous and non-collagenous proteins reflects on bone 
mineralization.  
5.6.1 Osteocytes and ECM markers  
Mechanical loading of bone further affects the morphology of osteocytes. The presence of 
type I collagen around the borders of osteocytes were seen in this study at all-time points 
of healing (Figure 10 A, A1). This adheres to previous report which showed that 
osteocytes align to the collagen to preserve ECM integrity [145]. This study showed the 
decline in osteocytes count (spindle, spherical, empty lacunae) with the progression of 
healing (Figure 12). This suggests the urgent need of osteocytes during early phase to 
support the ECM structure, the count then lowered once the mechanical stability reached. 
El Khassawna T et al. 2015 reported the increase in empty lacunae and irregular canaliculi 
network of osteocytes in osteoporotic rat model [146]. Lanyon LE. 1993 also showed the 
arrangement of osteocytes influence the bone modeling and remodeling [147]. 
Osteocytes inhibit osteoclastic bone resorption by producing signaling molecule like 
MEPE around high bone loading areas [148]. This study showed a wave like pattern in the 
activity of MEPE during fracture healing (Figure 13 A, B). This transitional change in 
MEPE suggests its possible role in bone homeostasis, by maintaining osteoblast and 
osteoclast activity. Jain A et al. 2004 reported the decrease in MEPE serum level with the 
increasing age of patients and maintenance of bone metabolism [149]. Osteoblast 
activation also relies on MAPK pathway. Yan YX et al. 2012 reported the proliferation of 
osteoblasts in in-vitro via activation of ERK in response to mechanical strain [150]. ERK 
immunostaining in this study showed lower activity during early phase of healing and 
higher at the late phase of healing (Figure 13D). The higher ERK activity correlates with 
the need of mineralization of new matrix to progress the healing. Lai CF et al. 2001 also 
showed the importance of Erk for cell differentiation and growth of human osteoblastic 
cells to complete bone mineralization [23]. Further, this study showed the feedback 
mechanism between MEPE and ERK during fracture healing (Figure 13). This reflects on 
well-maintained bone metabolism during the healing events. El Khassawna T et al. 2015 
reported higher MEPE and ERK signal in osteoporotic animal model reflecting on 
imbalanced bone metabolism [146]. David V et al. 2009 reported the defect in growth and 
mineralization with altered bone-renal vascularization due to over-expression of MEPE in 
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a murine model [151]. Intriguingly, Chen Z et al. 2015 reported impaired chondrocyte 
differentiation due to deletion of Erk1 and Erk2 from a mouse model [152]. This suggests 
that a fine balance between MEPE and ERK is important to prevent ECM related 
pathologies. 
The integrity of ECM further relies on the gene expression of specific markers important 
for fracture healing. In this study, upregulation of Acan, which is a part of ECM was 
detected at D10. This suggests that Acan plays an important role in ECM maintenance 
during bone mineralization. Watanabe H et al. 1998 reported that Acan binds to 
hydroxyapatite to prevent cartilage from compression under stress [153]. Lauing KL et al. 
2014 showed that Acan is essential for chondrocytes organization and survival during 
embryonic limb development [154]. Therefore, loss of Acan can result in severe 
complexity like chondrodysplasias [155]. Roughley PJ et al. 2014 showed that degradation 
of Acan results in articular cartilage among osteoarthritis patients [156]. Further, several 
factors responsible for ECM organization like Mmp2, Mmp9, and Mmp13 were 
differentially expressed in this study. The presence of Mmp genes in this study directs to 
their importance in ECM organization and degradation. Mosig RA et al. 2007 reported the 
onset of arthritis and joint contraction in Mmp2-/- mouse model, that lead to decreased 
bone mineralization [157]. Neuhold LA et al. 2001 reported the induction of osteoarthritis 
in mice due to excessive Mmp13 activity [158]. This indicates towards the essential role of 
Mmp2 and Mmp13 in fracture healing as well as in the prevention of skeletal 
abnormalities. 
Taken together, histological evaluation and differential gene expression involved in ECM 
showed a cross talk of different cell types and multifunctional genes in reaching bony 
bridging and mechanically stable bone. The results showed that loss of ECM genes can 
result in pathological conditions affecting the balanced cellular activity.  
5.7 Mitochondrial activity 
Mitochondrion is the powerhouse of cell. Energy production is required for cell 
proliferation and differentiation. Few studies reported changes in mitochondrial gene 
expression during fracture healing [159], while a detailed analysis is still required. This 
study for the first time -to my knowledge- describes the changes in mitochondrial genes 
during successful fracture healing. 
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Oxidative stress during injury produces ROS that comes from mitochondrion. Gpx1 is a 
mitochondrion origin antioxidant enzyme, which was significantly downregulated in this 
study at D3 and D7. Gpx1 reduces hydrogen peroxidases to water radicals to prevent 
oxidative stress and preserve homeostasis [160]. Mlakar SJ et al. 2010 showed Gpx1 
polymorphism associates with therapeutic potential to prevent oxidative damage in 
osteoporotic patients [161]. GPX1 immunostaining followed by histomorphometry 
showed a tendency of higher GPX1 positive area with the healing progression (Figure 
14B). This points to the higher need of GPX1 in late phase of healing. Lean JM et al. 2005 
showed increased bone loss and osteoclast formation in the presence of hydrogen 
peroxidase [162]. The higher GPX1 signal at late healing event indicates towards the need 
of anti-oxidant activity to preserve bone homeostasis. Further, increased signal of GPX1 in 
osteocytes vicinity as seen in this study suggests the cross talk between ECM and 
mitochondrion to maintain bone homeostasis (Figure 14C).  
At the time of injury, the energy demand increases which reflects on highest number of 
DEGs during the early phase of healing. The downregulation of Oxct1 which is an 
essential part for ketone body catabolism was detected in this study at D3 and D7. 
Fenselau A et al. 1975 reported lower level of ketone bodies in normal liver while higher 
in the malignant cells to grow fast [163]. Cotter DG et al. 2011 reported ketone body 
oxidation is required for postnatal survival in mice [164]. Further, they showed the 
induction of metabolic condition like diabetes in Oxct1-/- mice. This suggests that normal 
fracture healing and prevention of metabolic bone diseases needs ketone bodies for energy 
source.  
Signal transduction and mineral transport is essential for cellular activity besides energy 
need. Vdac3 which forms the clear channel to mediate metabolite flux through membranes 
were downregulated in this study at D3, D7, and D21. This might correlate with the 
cellular signaling during the fracture healing. Majumder S et al. 2013 showed that Vdac3 
negatively regulates ciliogenesis which is important for cell signaling and cell cycle [165]. 
Reina S et al. 2016 reported Vdac3 as a potential marker to diagnose mitochondrial 
dysfunction and ROS signaling [166]. Downregulation of Vdac3 in fracture healing as 
seen in this study prevent any disruption of centrosome and energy production.  
Slc25a5 which is a component of mitochondrial inner membrane was significantly 
upregulated in this study at D10. The upregulation points to Slc25a5 role in inducing cell 
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proliferation. Klingenberg M. 1993 showed that Slc25a5 catalyzes the exchange of 
Adenosine diphosphate (ADP) and ATP between cytosol and mitochondrion [167]. This 
energy exchange via Slc25a5 points to the requirement for cell proliferation. 
Taken together, this data showed the differences in cellular and molecular aspect of 
mitochondrial gene. Although the mitochondrial genes were downregulated during 
inflammatory phase, the success of bone healing still relies on mitochondrial genes. 
Further, differentially expressed mitochondrial genes showed a connection with systemic 
skeletal disease like osteoporosis and mitochondrial dysfunction. 
5.8 Ribosomal activity 
Ribosome regulates protein synthesis which is important for cellular growth, proliferation, 
differentiation, and apoptosis [37]. Any disruption in ribosome biogenesis can result in 
congenital skeletal differences [168]. The role of ribosomal genes in fracture healing is not 
well studied before. This study attempts to understand the changes in ribosomal gene 
expression in fracture healing. 
Cell cycle control and transcriptional regulation is important for the progress of fracture 
healing.  Downregulation of Ubb, which controls the degradation of proteins was seen in 
this study at D3 and D7. The downregulation of Ubb directs towards the increased cellular 
activity during the inflammatory phase. Hochstrasser M. 1995 showed that ubiquitin 
proteasome complex acts as a governing factor in the cell cycle progression [169]. 
Dennissen FJ et al. 2011 showed the association of mutation in Ubb with the onset of 
neurodegenerative diseases [170]. This points to the additional role of Ubb besides bone 
healing. Further, UBB immunostaining followed by histomorphometry showed higher 
UBB positive stain at D7, and then lowered with progression of healing (Figure 15B). This 
reflects on the need of cell differentiation at early stage of healing. Furthermore, several 
blood vessels showed UBB positive stain in this study (Figure 15C). This suggest potential 
role of UBB in vascularization as well. Previous studies also showed an increase in 
angiogenesis in aortic tissue from rats in presence of extracellular ubiquitin [171]. 
Therefore, Ubb is essential for protein degradation as well as for blood vessel formation. 
Controlled expression of cell cycle regulators are important for cell division. The 
downregulation of E2f2 which controls cell cycle regulation was seen in this study at D21 
and D28. This downregulation at late healing phase might point to the removal of extra 
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cells that are not required. Pagliarini V et al. 2015 reported the downregulation of E2f 
under stress induces apoptosis of cells to prevent metastasis [172]. Iglesias-Ara A et al. 
2010 reported that E2f2 acts as one of the suppressor of hematopoietic progenitor 
expansion resulting in DNA damage [173]. Therefore, downregulation of E2f2 is essential 
for cell proliferation and differentiation. 
Ribosomal proteins also plays an important role in preventing oxidative stress condition. 
The upregulation of Mt3 which is induced under hypoxic condition was detected in this 
study at D10, D14, and D21. The upregulation directs towards establishment of bone 
homeostasis. Hwang YP et al. 2008 showed that Mt3 controls the intracellular level of 
ROS in human neuroblastoma cell lines by regulating an antioxidant enzyme [174].  
Collectively, this study showed the important role of ribosomal proteins in bone 
homeostasis and cellular growth. UBB at cellular level showed an overlapping role in 
angiogenesis and ribosomal activity. Further, the downregulation of ribosomal genes 
showed a potential role in preventing cellular damage. 
5.9 Immune response 
Immune system is important to provide defense against invading pathogens. An emerging 
field of osteoimmunology focuses on understanding the interplay between immune system 
and skeletal system [175]. This study aimed at understanding the role of innate and 
adaptive immune system in fracture healing. Both upregulation and downregulation of 
genes involved in immune response were detected in this study during fracture healing.  
Preventing infection from virus or microbes is important for the successful fracture 
healing. In this study, Snca was significantly downregulated at D10, D21, and D28. Snca 
is a conserved protein in central nervous system and its role in pathogenesis of Parkinson 
disease is well-known [176]. Calabrese G et al. 2016 reported using bioinformatics 
analysis that Snca regulates bone network homeostasis an ovariectomy induced bone loss 
[177]. Shameli A et al. 2016 reported the hindered development of B-lymphocytes and T-
lymphocytes in Snca knock-out model [178]. The presence of Snca in this study points to 
the defense mechanism against pathogens and bone loss. Labrie V et al. 2017 recently 
reported the increased expression of Snca around virus infection in brain [179]. This 
suggests that upregulation of Snca takes place under the attack of pathogens. This study 
showed the differential expression of B2m which displays antimicrobial activity. B2m was 
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downregulated at D3 and D7 while upregulated at D10 in this study. Xie J et al. 2003 
reported that B2m acts as a negative regulator of immune system and the raised serum 
level of B2M was seen among rheumatoid arthritis and multiple myeloma patients [180]. 
The early downregulation of B2m in this study points to increased immune response 
during early phase of healing when compared with intermediate or late healing phase.  
Neutrophils are among the first immune cells recruited at the site of injury to prevent 
infection. This study showed the upregulation of Ctsg which is a protease complex. Wilgus 
TA et al. 2013 showed that neutrophils produces Ctsg to target ECM proteins, thereby 
degrading membrane proteins [181]. Bangalore N et al. 1990 reported the antimicrobial 
role of Ctsg besides degrading membrane proteins to prevent infection [182]. Zou F et al. 
2017 reported that downregulation of Ctsg prevents the increased T cell activity, thereby 
affecting bone remodeling process [183]. This indicates the multiple role of Ctsg in 
fracture healing. 
Taken together, this study helped in providing a slight insight into immune response in 
fracture healing. Further, differential expression of genes and their roles was useful to gain 
information about the cross-talk of bone and immune system. 
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Figure 16: Blueprint of differential expressed genes involved in key biological processes 
during fracture healing. To illustrate the complexity of fracture healing, DEG involved in 
the targeted processes were mapped across time points. Differential gene expression was 
visualized from D3 (pink) until D28 (grey). Angiogenesis genes were differentially 
expressed from D3 until D14. Ossification genes were differentially expressed at all time 
points. Higher ECM genes were present at D3 until D14 compared with D21 and D28. 
Higher immune response genes were downregulated at D3, D7, upregulated at D10, D14 
and downregulated at D21, D28. Ribosomal and mitochondrial genes were highly 
downregulated at D3 and D7.  
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6.  CONCLUSION 
This study offers a new prospective about the overlapping healing events of fracture 
healing and the application of phase targeted approach for treating non-union or human 
skeletal disorders. The use of whole genome sequencing via microarray enabled the 
detailed investigation of differentially expressed genes across the time points of healing. 
This study presents the importance of FC cut-off comparison as a pre-requisite for 
differential analysis. The importance of angiogenesis, ossification, ECM regulation, and 
immune cells during fracture healing is well known. This study, however, showed the 
presence of overlapping genes among the key biological processes during healing. The 
cross-talk between different genes pointed to the overlapping transition through healing 
progression. This study showed the importance of differentially expressed genes like 
Col1a1, Mmp13, Ibsp, Serpinf1 in preventing skeletal abnormalities, delayed healing, or 
non-union cases. 
The importance of ECM during fracture healing, systemic skeletal diseases, and 
therapeutics designing is well known. Here, the study showed the cross-talk between 
different cell types involved in signaling pathways and orientation of collagen fibers 
during fracture healing. The computation quantification of collagen fibers gained from 
Sirius red stain images reflects on bone healing. Further examination of ossification genes 
showed a balanced expression of collagenous and non-collagenous proteins. 
This study for the first time presents the contribution of mitochondrial and ribosomal 
genes in the successful fracture healing. It explains the role of mitochondrial genes 
specifically during inflammatory phase to preserve bone homeostasis, by preventing the 
risk of osteoporosis. The combined differential gene expression and immunostaining used 
here revealed that mitochondrial genes play an essential part in fracture healing. Further, 
this study show the high potential of ribosomal genes in preventing cellular damage during 
fracture healing. 
This work provided a blueprint of differentially expressed genes during successful healing 
(Figure 16). This study identified novel candidate markers for bone healing to develop 
phase-directed treatment.  
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7.  IMPLICATIONS AND FUTURE DIRECTION 
This thesis using microarray data analysis and histology indicated the potential role of six 
main biological processes in the successful bone healing. 
This study investigated the importance of angiogenesis, ossification, ECM, immune 
response, mitochondrial, and ribosomal activity but not the muscle cells in fracture 
healing. Muscles provide rich supply of oxygen and nutrients to the surrounding tissue. 
Some cases with delayed healing results from high energy trauma with extensive damage 
of soft tissue [184]. Therefore, investigation of bone and muscle interaction can provide 
further insight to the fracture healing mechanism. 
This thesis showed a new therapeutic potential of phase targeted strategy for successful 
bone healing and for the treatment of diseases like osteoporosis and osteogenesis 
imperfecta. Nonetheless, the optimization of phase targeted markers is required to 
successfully improve the therapeutic outcome. Additional network analysis study between 
phase specific markers would unravel the complex underlying interactions.  
The prediction of fragility fractures in osteoporotic patients depends on the identification 
of structural and genetic basis [185]. Another outlook to this study would be to understand 
the association between transcriptomic data and bone structural properties via genotype-
phenotype correlation. The correlation will indeed provide a clearer picture of diagnostics 
potential. 
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APPENDICES 
APPENDIX 1 
Preparation of samples for paraffin embedding 
MATERIAL  
Ethanol (100%) Methyl Ethyl Ketone denaturized solution; Herbeta Drug, Berlin, Germany 
EDTA Decalcifying solution; Herbeta Drug, Berlin, Germany  
Paraffin EM-400 Embedding Medium Paraffin; Leica Biosystems, Nussloch GmbH, Germany 
Paraffin Dispenser Leica EG1120, Leica Biosystems, Nussloch GmbH, Germany 
PFA 4 % W/V Paraformaldehyde powder in DEPC treated water (pH = 9.1) 
Samples dehydration machine procedure: 
Step Solution Time (min.) Repetition 
1. Ethanol (70%) 60 1x 
2. Ethanol (80%) 60 1x 
3. Ethanol (96%) 120 2x 
4. Ethanol (100%) 120 2x 
5. Ethanol (100%) 180 1x 
6. Xylol 60 2x 
7. Paraffin 120 2x 
Protocol: 
1. Fix the bone samples in 4% PFA solution for 48 hours. 
2. Decalcify bones at 4 °C in 1:2 mixture of 4% PFA and EDTA for three weeks. Change solution 
twice in a week. 
3. Place the bones in dehydration cassettes and rinse for 1 hour under running tap water. 
4. Dehydrate the samples in machine as mentioned in the table above; all steps are carried out at RT. 
5. Pre-heat the casting molds at 60 °C in incubator to prevent instant solidifying. 
6. Place the samples in the mold holding gently using forceps. 
7. Place the mold with samples on the hot plate and pour paraffin from the heated tank. 
8. Remove the mold from hot plate carefully and place it on -5 °C cooling plate for 15 minutes. 
9. Remove the embedded samples from the mold and store at RT. 
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APPENDIX 2 
Sirius Red Staining 
MATERIAL  
Sirius Red Picro Sirius Red Stain Kit (ab150681, Abcam, Cambridge, MA, USA) 
Acetic Acid Acetic Acid Solution (ab150681, Abcam, Cambridge, MA, USA) 
Protocol: 
1. Deparaffinize sections via Xylene (2 x 10 minutes) and descending percentage of ethanol 100%, 
96%, 70% for 2 minutes each. 
2. Rehydrate in distilled water for 2 minutes. 
3. Stain in Sirius red solution for 1 hour. 
4. Rinse in acetic acid solution (2x). 
5. Rinse in absolute ethanol.  
6. Clear in absolute ethanol, two changes for 5 minutes each. 
7. Cover slip the slides after mounting using Vitroclud. 
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APPENDIX 3 
Trichrome Masson Goldner Stain 
MATERIAL  
Weigert Hematoxylin 
solution A 
Art. No. X906.1, Carl Roth GmbH and Co. KG, Karlsruhe, Germany 
Weigert Hematoxylin 
solution B 
Art. No. X907.1, Carl Roth GmbH and Co. KG, Karlsruhe, Germany 
Goldner’s staining I Ponceau-Fuchsin solution (Art. No. 3469.1, Carl Roth GmbH and Co. KG, 
Karlsruhe, Germany) 
Goldner’s staining II Phosphotungstic acid-Orange G solution (Art. No. 3470.1, Carl Roth GmbH 
and Co. KG, Karlsruhe, Germany) 
Goldner’s staining III Light green SF yellowish solution (Art. No. 3473.1, Carl Roth GmbH and 
Co. KG, Karlsruhe, Germany 
Glacial Acetic acid Acetic acid (glacial) 100%  (1000631000, Merck KGaA, Darmstadt, 
Germany) 
Protocol: 
1. Deparaffinize sections via Xylene (2 x 5 minutes) and descending percentage of ethanol 100%, 
96%, 70% for 5 minutes each. 
2. Rinse in distilled water for 2 minutes. 
3. Mix Hematoxylin solution A and solution B in 1:1 concentration. 
4. Stain the sections with mixed solution for 3 minutes. 
5. Rinse the sections in running tap water for 10 minutes. 
6. Stain the sections with Goldner’s staining solution I for 8 minutes. 
7. Rinse the sections in 1% acetic acid solution for 30 seconds. 
8. Stain the sections with Goldner’s staining solution II for 5 minutes. 
9. Rinse the sections in 1% acetic acid solution for 30 seconds. 
10. Stain the sections with Goldner’s staining solution III for 4 minutes. 
11. Rinse the sections in 1% acetic acid solution for 3 minutes. 
12. Dehydrate in ascending percentage of ethanol 70%, 96%, 100% for 5 minutes each. 
13. Clear in Xylene, two changes for 5 minutes each. 
14. Cover slip the slides after mounting using Vitroclud. 
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APPENDIX 4 
Silver Nitrate Staining 
MATERIAL  
Formic acid Formamide (EMD 1.09684.1000, Merck KGaA, Darmstadt, Germany) 
Gelatin Gelatin from bovine skin (G9391, Sigma-Aldrich Chemie GmbH, Munich, 
Germany) 
Silver nitrate Silver nitrate for analysis (ACS, ISO 131459, AppliChem GmbH, Darmstadt, 
Germany) 
Solution A Add 0.5g Gelatin in 24.75 ml double distilled water, mix well at room 
temperature. Add 250 µl Formic acid.  
Solution B 50% silver nitrate prepared in double distilled water 
Sodium thiosulfate Sodium thiosulfate pentahydrate (10102-17-7, Merck KGaA, Darmstadt, 
Germany) 
Protocol: 
1. Deparaffinize sections via Xylene (2 x 5 minutes) and descending percentage of ethanol 100%, 
96%, 70% for 5 minutes each. 
2. Rehydrate the sections via double distilled water (2 x 5 minutes). 
3. Mix solution A and B in 1:2 concentration. 
4. Stain with the mixed solution for 73 minutes. 
5. Rinse the sections in distilled water to stop the reaction. 
6. Wash in distilled water for 5 minutes. 
7. Place in 5% Sodium thiosulfate for 10 minutes. 
8. Wash in distilled water for 5 minutes. 
9. Dehydrate in ascending percentage of ethanol 70%, 96%, 100% for 5 minutes each. 
10. Clear in Xylene, two changes for 5 minutes each. 
11. Cover slip the slides after mounting using Vitroclud. 
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APPENDIX 5 
Immunohistochemical Staining 
MATERIAL  
TBS TRIS PUFFERAN®, 4855.2, Carl Roth GmbH, Karlsruhe, Germany; Sodium 
chloride, 31434-1KG-R, Sigma Aldrich Chemie GmbH, Steinheim, Germany; 
Hydrochloric acid 25%, 1.00316.1011, Merck KGaA, Darmstadt, Germany 
Triton Triton® X-100, 1.08643.1000, Merck KGaA, Darmstadt, Germany 
Citrate buffer Citric acid monohydrate, 3958.2, Carl Roth GmbH, Karlsruhe, Germany; tri-
Sodium citrate dihydrate, 1.06448.1000,  Merck KGaA, Darmstadt, Germany 
Blocking solution BLOXALLTM Blocking solution, SP-6000, Vector Laboratories, Inc., 
Burlingame, CA, USA 
ABC-AP kit Alkaline phosphatase, AK 5200, Vectastain ABC kit, Vector Laboratories, Inc., 
Burlingame, CA, USA 
ASMA (1:100) Primary antibody, rabbit polyclonal, TA353561, Acris Antibodies GmbH, 
Herford, Germany 
Osteocalcin (1:100) Primary antibody, mouse monoclonal, MAB1419, R&D Systems, Inc., 
Minneapolis, MN, USA 
MEPE (1:100) Primary antibody, rabbit polyclonal, HPA038004, Sigma-Aldrich Chemie 
GmbH, Munich, Germany 
ERK (1:100) Primary antibody, rabbit monoclonal, ab32081, Abcam, Cambridge, MA, USA 
Ubiquitin (1:150) Primary antibody, rabbit polyclonal, ab7780, Abcam, Cambridge, MA, USA 
Glutathione 
peroxidase 1 (1:325) 
Primary antibody, rabbit monoclonal, ab22604, Abcam, Cambridge, MA, USA 
AP-substrate kit Vector® Red Alkaline phosphatase substrate, SK-5100, Vector Laboratories Inc., 
Burlingame, CA, USA 
Methyl green Methyl green, H-3402, Vector Laboratories Inc., Burlingame, CA, USA 
Acetone  
Glacial acetic acid Glacial Acetic Acid (EC Number 2005807, Merck, Darmstadt, Germany) 
Formic acid Formamide (EMD 1.09684.1000, Merck KGaA, Darmstadt, Germany) 
Gelatin Gelatin from bovine skin (G9391, Sigma-Aldrich Chemie GmbH, Munich, 
Germany) 
Silver nitrate Silver nitrate for analysis (ACS, ISO 131459, AppliChem GmbH, Darmstadt, 
Germany) 
Solution A Add 0.5g Gelatin in 24.75 ml double distilled water, mix well at room 
temperature. Add 250 µl Formic acid.  
Solution B 50% silver nitrate prepared in double distilled water 
Sodium thiosulfate Sodium thiosulfate pentahydrate (10102-17-7, Merck KGaA, Darmstadt, 
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Germany) 
 
General Protocol (for all IHC): 
1. Deparaffinize sections via Xylene (2 x 5 minutes). 
2. Wash in technical acetone for 10 minutes. 
3. Mix technical acetone and washing buffer in 1:1 concentration. Wash the slides in the mixed 
solution for 10 minutes. 
4. Rehydrate the slides in washing buffer (2 x 10 minutes). 
5. Antigen retrieval using citrate buffer solution (pH = 6) for 1 hour at 60 °C. 
6. Wash the slides in washing buffer at RT (2x). 
7. Mark around the section using fat marker. 
8. Inhibit endogenous peroxidase using blocking solution for 10 minutes at RT. 
9. Wash the slides in washing buffer (2 x 5 minutes) at RT. 
10. Add one drop of universal serum in 5 ml of TBS. Incubate the slides for 20 minutes at RT. 
11. Incubate with primary antibody at 4°C overnight. 
12. Wash in washing buffer (2 x 5 minutes). 
13. Prepare secondary antibody by adding a drop of universal serum and a drop of biotinylated 
universal antibody in 2.5 ml of TBS. Incubate with secondary antibody for 30 minutes at RT. 
14. Prepare ABC-AP complex 30 minutes before use. Add 25 µl Reagent A and 25 µl Reagent B in 
2500 µl of TBS.  
15. Rinse the slides in washing buffer (2 x 5 minutes). 
16. Incubate in ABC-AP complex for 30 minutes at RT. 
17. Rinse the slides in distilled water for 5 minutes. 
18. Prepare AP substrate mix by adding all three reagents (2 drops each) in 5 ml of 150 Mm Tris-HCl 
buffer (pH = 8.3). 
19. Incubate with AP substrate until a clear red color is detected. 
20. Rinse in distilled water to stop the reaction (2 x 5 minutes). 
21. Counter stain with methyl green for ASMA and Osteocalcin; toluidine blue for MEPE and ERK; 
silver nitrate for Ubiquitin and Gpx1. 
22. Cover slip the slides after mounting using Vitroclud. 
 
Protocol for use of Methyl Green as counter-stain: 
1. Heat the hot plate at 60°C prior to stain. 
2. Incubate the slides with methyl green for 5 minutes at 60°C. 
3. Stop the reaction by washing the slides in distilled water. 
4. Rinse the slides in distilled water for 1 minute. 
5. Add 50 µl glacial acetic acid in 100 ml acetone. Dip the slides 5-10 times in the mixed solution. 
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6. Dip the slides in 96% and 100% ethanol (5 times each). 
7. Dry the slides inside the incubator for 30 minutes at 60°C. 
8. Cover slip the slides after mounting using Vitroclud. 
Protocol for use of Toluidine Blue as counter-stain: 
1. Prepare toluidine blue solution in 1:1 concentration. 
2. Rinse the slides in toluidine blue solution for 35 seconds at RT. 
3. Stop the reaction by washing in distilled water. 
4. Dehydrate in 100% ethanol for 5 minutes. 
5. Clear in Xylene (2 x 5 minutes). 
6. Cover slip the slides after mounting using Vitroclud. 
Protocol for use of Silver Nitrate as counter-stain: 
1. Mix solution A and B in 1:2 concentration. Stain the slides using mixed solution for 35 minutes at 
RT. 
2. Stop the reaction by washing the slides in double distilled water 
3. Rinse the slides in double distilled water (3x). 
4. Prepare 5% sodium thiosulfate solution. Incubate the slides with sodium thiosulfate for 2 minutes at 
RT. 
5. Rinse in distilled water for 5 minutes. 
6. Dehydrate by rinsing in 70% ethanol for 2 minutes and 100% ethanol for 10 minutes. 
7. Dry the slides inside the incubator for 30 minutes at 60°C. 
8. Cover slip the slides after mounting using Vitroclud. 
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APPENDIX 6 
Histomorphometry using ImageJ (version 1.51) 
Pre-requisites for software: 
1. Java version 8 
2. Trainable Weka Segmentation plugin (v 3.2.13) 
3. Minimum of 4 gb RAM. 
Protocol (also depicted as step-wise screenshots): 
1. Import Image onto ImageJ (Drag and drop/ File → Open). 
2. Go to Image → Stacks → Tools → Montage to Stack. Select one stack that represents all segment 
of a histological stain. 
3. Go to Plugins → Segmentation → Trainable Weka Segmentation. This will open a window with 
different options. 
4. The default number of classes are two, but it can be increased up to an arbitrary number based on 
the analysis using “Create new class” option present on the left panel. The name of first two classes 
can be changed by going to “Settings” option. Define the classes on the basis of colors visualized in 
a specific stain. The points can be defined for each class using polygon tool or line. 
5. After defining 10-15 points for each class, go to “Train Classifier”. It will take time according to the 
memory of computer and image size. 
6. The log window will provide the information once segmentation is finished. Go to “Create result” 
to verify the segmentation done by plugin. 
7. If the segmentation done is comparable to the initial image, go to “save classifier” and “save data” 
options to save time for the analysis of images from the same histological stain. 
8.  All other images from the same stain can be analyzed by uploading classifier and data file using 
“Load Classifier” and “Load Data” option present on Trainable Weka Segmentation window. 
9. After segmentation, go to Analyze → Measure to obtain the percentage of area covered by each 
defined class in a picture. 
10. Go to Analyze → Set Scale. The pixel size depends upon the microscope and magnification used 
for capturing the picture. The area percentage can be converted into ASBMR defined scale (mm or 
µm) by multiplying the scale of image with the percentage obtained from the previous step.  
11. The obtained results can be statistically tested later. 
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APPENDIX 7 
RNA isolation and Quality Control 
MATERIAL  
RNase free water Ambion® Nuclease-Free Water, Thermo Scientific GmbH, Karlsruhe, Germany 
Trizol Reagent TRIzol TM Reagent, Invitrogen, Thermo Scientific GmbH, Karlsruhe, Germany 
Isopropyl alcohol 127682001, Carl Roth GmbH, Karlsruhe, Germany 
Protocol for RNA isolation: 
1. Avoid any kind of contamination. Work on clean bench. 
2. Pulverize flash frozen calluses using pestle and mortar under continuous cooling with liquid 
nitrogen. 
3. Transfer the material to a 2 ml sterile Eppendorf tube. 
4. Add 1 ml of TRIzol Reagent for each 200 mg of tissue. 
5. Homogenize the samples in 15 seconds interval while kept in ice using a homogenizer (T10, Ultra 
Turrax, IKA-Werke GmbH & Co. KG, Staufen, Germany). 
6. Add 0.2 ml chloroform per 1 ml of TRIzol Reagent. Securely close the sample tubes and vortex 
vigorously for 15 seconds. 
7. Incubate the homogenized sample for 15 minutes at RT to allow complete dissociation of 
nucleoprotein complexes. 
8. Centrifuge the samples to remove cell debris at no more than 12,000 x g for 15 minutes at 2-8°C. 
9. After centrifugation, the mixture separates into three distinct phases: phenol-chloroform phase as 
lower red, an interphase, and a colorless upper aqueous phase. RNA remains exclusively in the 
aqueous phase. Carefully transfer the upper aqueous phase into fresh tube without disturbing the 
interphase. Then, measure the volume of the aqueous phase.  
10. Add 200 µl of chloroform and 1 ml of TRIzol and repeat step 8-9. 
11. Add 500 µl isopropyl alcohol per 1 ml of TRIzol Reagent used for the initial homogenization to 
precipitate RNA from the aqueous phase. Incubate samples for 10 minutes at RT. 
12. Centrifuge at not more than 12,000 x g for 10 minutes at 2-4°C. The RNA precipitate, often 
invisible after centrifugation, forms a gel-like pellet on the side and bottom of the tube. 
13. Carefully remove the supernatant completely. Wash the RNA pellet once with 75% ethanol, adding 
at least 1ml of 75% ethanol per 1 ml of TRIzol Reagent used for the initial homogenization. Vortex 
the tube and then centrifuge at no more than 7,500 x g for 5 minutes at 2-8°C. Repeat the washing 
procedure once. Remove the leftover ethanol completely. 
14. Dry the RNA pellet by air-drying/vacuum-drying for 5-10 minutes. It is crucial not to let the RNA 
pellet dry completely as it will greatly affect RNA solubility. Partially dissolved RNA samples 
generally have an A260/A280 ratio < 1.6. Dissolve RNA in RNase free water using pipette. 
15. Use picodrop spectrophotometer to determine the sample concentration and purity. Use picodrop 
pipette tips and a 10 µl Gilson pipette to take 2 µl of sample to measure OD at 260nm and 280nm. 
The A260/A280 ratio should be above 1.7, for microarray analysis RNA integrity in bio-analyzer 
should be above RIN. 
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16. Usually total RNA isolated using TRIzol method needs to be further cleaned using DNAse I 
(Invitrogen Life Technologies) protocol. 
 
APPENDIX 8 
Quality assessment of Beadchip array using R 
Pre-requisite for the analysis: Install R from https://cran.r-project.org (v 3.0.3) 
Protocol to change the working directory in R: 
1. Open R console. 
2. Go to File → Change dir… → “provide the path to the folder raw data is saved”. 
The code below shows the protocol for quantile normalization for the Illumina beadchip array: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
source (“https: //bioconductor.org/biocLite.R”) 
biocLite (c (“illuminaio”, “beadarray”, “limma”, “illuminaMousev2.db”)) # install the required packages 
library (illuminaio) # library command load the installed packages 
library (beadarray) 
library (limma) 
library (illuminaMousev2.db)  
Idatfiles <- dir (pattern = “idat”) # Illumina’s raw data is saved in idat file format, this command will 
read and store all idat files present in the current directory under “Idatfiles” 
# Annotation for Illumina beadchip array can be downloaded from NCBI-GEO or from Illumina web 
site. The file with annotation usually have extension at “.txt” or “.bgx”. Unzip the downloaded file and 
save it in the current directory 
Bgxfile <- dir (pattern = “bgx”) # the command will read the bgx file and store it under “Bgxfile” for 
further analysis. 
X <- read.idat (Idatfiles, Bgxfile) # the command reads the information stored in “Idatfiles” and 
“Bgxfile” and store it in X variable 
Sig_value <- detectionPvalues (X) # this command detects the p-value within probes 
Y <- propexpr (X) # this command estimates the proportion of expressed probes in array data 
Z <- neqc (X) # this command performs background correction, log transformation and quantile 
normalization for Illumina expressed data 
# Save the outputs in txt file using following commands 
write.table (Sig_value, file = “p_values.txt”, sep = ‘\t’, row.names = F) 
write.table (Y, file = “proportion.txt”, sep = ‘\t’, row.names = F) 
write.table (Z, file = “normalized_data.txt”, sep = ‘\t’, row.names = F) 
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APPENDIX 9 
Hierarchical clustering of DEG using R 
Pre-requisite for the analysis: Install R from https://cran.r-project.org (version 3.0.3) 
Protocol to change the working directory in R: 
1. Open R console. 
2. Go to File → Change dir… → “provide the path to the folder in which gene list is saved”. 
The code below shows the protocol to perform hierarchical clustering based on expression pattern: 
 
 
 
 
 
 
 
 
 
 
 
 
install.packages(c("pvclust", "biclust", "modeltools", "som", "flexclust", "cluster", "scatterplot3d", 
"gplots", "e1071", "kernlab")) # install the required packages from the Comprehensive R archive 
network  
source ("http://www.bioconductor.org/biocLite.R") # install required packages from Bioconductor 
biocLite (c("geneplotter", "ellipse", "ctc"))  
List <- read.delim ("genelist.txt", header=T, sep="\t") # read the gene list saved in txt file 
rownames(List) <- List [,1];  
List <- as.matrix(List [,-1]) # transform gene list into matrix object 
 dim(List) # this command can be used to re-check the dimensions of final sample matrix  
#Hierarchial Clustering 
library(gplots);  
myheatcol <- redgreen(75) # import color scheme for heatmap visualization 
List _scale <- t(scale(t(List))) # centers and scales the sample data 
hr <- hclust(as.dist(1-cor(t(mydatascale), method="pearson")), method="complete") # Cluster rows by 
Pearson correlation. 
Heatmap (List, Rowv=as.dendrogram(hr), Colv=NA, col=myheatcol, scale="row") #complete heatmap 
with gene list 
png("Heatmap.png",    # create PNG for the heat map         
  width = 20*300,        # 5 x 300 pixels 
  height = 60*300, 
  res = 600,            # 300 pixels per inch 
  pointsize = 12) 
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APPENDIX 10 
Functional annotation using NCBI-DAVID (version 6.7) 
Protocol (also depicted with screenshots): 
1. Go to https://david.ncifcrf.gov/ 
2. Click on “Start Analysis” 
3. Copy and paste/ Upload your gene list onto the left panel “Enter Gene List”. 
4. Select the identifier category for the gene list IDs added before. 
5. Specify the list type as “Gene list” to submit for analysis. 
6. Select the species of interest to get gene annotation. 
7.  Click on “Functional annotation tools” option provided by DAVID. 
8. Click on “Functional Annotation table” to obtain the information about different selected functional 
categories. 
9. Click on “Download file” to save the annotation info. 
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ABBREVIATIONS LIST 
Abbreviation   Term 
[%]    Percentage 
°C    Degree Celsius 
Acan    Aggrecan 
ADP    Adenosine diphosphate 
Ampd1   Adenosine monophosphate deaminase 1 
ANOVA   Analysis of variance 
Aqp1    Aquaporin 1 
ASMA    Alpha smooth muscle actin 
ATP    Adenosine triphosphate 
Atp5b    Adenosine triphosphate synthase subunit beta mitochondrial 
Atp5f1    ATP synthase H+ transporting mitochondrial f1complex 
B2m    Beta 2 microglobulin 
Bckdk    Branched chain ketoacid dehydrogenase kinase 
BMP    Bone morphogenetic protein 
BMU    Basic multicellular unit 
BSP    Bone sialoprotein 
Capns1   Calpain small subunit 1 
Ckmt2    Creatine kinase mitochondrial type 2 
Col10a1   Collagen type 10 alpha 1 
Col12a1   Collagen type 12 alpha 1 
Col1a1    Collagen type 1 alpha 1 
Col24a1   Collagen type 24 alpha 1 
Col2a1    Collagen type 2 alpha 1 
Col6a1    Collagen type 6 alpha 1 
Col9a2    Collagen type 9 alpha 2 
Coq9    Coenzyme q9 
Cox19    Cytochrome c oxidase assembly homolog 19 
Cox6a2   Cytochrome c oxidase subunit 6a2 
Cox7a1   Cytochrome c oxidase subunit 7a1 
Cox8b    Cytochrome c oxidase subunit 8b 
Cpt1b    Carnitine o-palmitoyltransferase 1 
Cpz    Carboxypeptidase z 
Crtap    Cartilage associated protein 
Cs    Citrate synthase 
Csde1    Cold shock domain containing protein e1 
Ctsg    Cathepsin g 
Ctsk    Cathepsin k 
Cyc1    Cytochrome c1 
Cyp27a1   Cytochrome p450 family 27 subfamily a member 1 
D    Day 
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DAVID   Database for Annotation, Visualization and Integrated 
Discovery 
Dcn    Decorin 
DEG    Differentially expressed genes 
DMP1    Dentin matrix protein 1 
DNA    Deoxyribonucleic acid 
Dusp26   Dual specificity phosphatase 26 
E2f2    E2f transcription factor 2 
ECM    Extracellular matrix 
Efemp2   Epidermal growth factor containing fibulin ECM protein 2 
ERK    Extracellular signal-regulated kinase  
Etfa    Electron transfer flavoprotein alpha subunit 
FC    Fold change 
Fcer1g    Fc fragment of IgE receptor 1g 
Fcnb    Ficolin b 
Fh1    Fumarate hydratase 1 
GPX1    Glutathione peroxidase 1 
Gstp1    Glutathione s transferase p1 
Hnrnph1   Heterogeneous nuclear ribonucleoprotein h1 
Hspa9    Heat shock protein family a member 9 
IBM    International business machines 
Ibsp    Integrin binding sialoprotein 
Ifitm2    Interferon induced transmembrane protein 2 
IHC    Immunohistochemistry 
IL-1    Interleukin 1 
Il11ra1    Interleukin 11 receptor subunit alpha 1 
IL-6    Interleukin 6 
KEGG    Kyoto Encyclopedia of Genes and Genomes 
Lcn2    Lipocalin 2 
Lox    Lysyl oxidase 
Lum    Lumican 
Lyrm5    Lyr motif containing protein 5 
MAPK    Mitogen activated protein kinase 
Mapk14   Mitogen activated protein kinase 14 
MATLAB   Matrix laboratory 
Mcm7    Minichromosome maintenance complex component 7 
M-CSF   Macrophage colony stimulating factor 
Mef2c    Myocyte enhancer factor 2c 
MEPE    Matrix extracellular phosphoglycoprotein 
Metap1   Methionyl aminopeptidase 1 
mg    Milligram 
Mgp    Matrix gla protein 
mm    Millimeter 
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Mmp13   Matrix metalloproteinase 13 
Mmp2    Matrix metalloproteinase 2 
Mmp9    Matrix metalloproteinase 9 
MMPs    Matrix metalloproteinase 
Mrpl33   Mitochondrial ribosomal protein l33 
Mrpl53   Mitochondrial ribosomal protein l53 
Mt3    Metallothionein 3 
Myom1   Myomesin 1 
NF-kB    Nuclear factor kappa-light-chain-enhancer of activated B 
cells 
nm    Nanometer 
Npm1    Nucleophosmin 1 
OCN    Osteocalcin 
Ogn    Osteoglycin 
ONC    Osteonectin 
OPG    Osteoprotegerin 
OPN    Osteopontin 
Oxct1    3-oxoacid CoA-transferase 1 
Pdia3    Protein disulfide isomerase family a member 3 
Pdk4    Pyruvate dehydrogenase kinase 4 
PFA    Paraformaldehyde 
Pglyrp1   Peptidoglycan recognition protein 1 
Plac8    Placenta specific 8 
Prdx2    Peroxidase 2 
Prdx3    Peroxidase 3 
Prf    Perforin 
Ptn    Pleiotrophin 
RANKL   Receptor activator of nuclear factor kappa B ligand 
ROS    Reactive oxygen species 
Rpl24    Ribosomal protein l24 
Rpl27    Ribosomal protein l27 
Rpl31    Ribosomal protein l31 
Rpl36al   Ribosomal protein l36a like 
Rps2    Ribosomal protein s2 
Rps3    Ribosomal protein s3 
Rps6    Ribosomal protein s6 
rRNA    Ribosomal ribonucleic acid 
Rsad2    Radical s-adenosyl methionine domain containing 2 
RT    Room temperature 
Runx2    Runt related transcription factor 2 
S100a8   S100 calcium binding protein a8 
Sdhc    Succinate dehydrogenase cytochrome b560 subunit 
SEM    Standard error of mean 
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Serpinf1   Serpin family f member 1 
Sh3pxd2b   Sh3 and Px domain containing protein 2b 
Slc25a11   Solute carrier family 25 member 11 
Slc25a20   Solute carrier family 25 member 20 
Slc25a37   Solute carrier family 25 member 37 
Slc25a5   Solute carrier family 25 member 5 
Slpi    Secretory leukocyte peptidase inhibitor 
Snca    Synuclein alpha 
SOST    Sclerostin 
Sp7    Specificity protein 7 
Sparc    Secreted protein acidic and cysteine rich 
Spp1    Secreted phosphoprotein 1 
SPSS    Statistical package for the social sciences 
Suclg1    Succinyl CoA ligase 1 
TCA    Tricarboxylic acid 
Tgf    Transforming growth factor 
Tgfbr1    Transforming growth factor beta receptor 1 
Tgfbr2    Transforming growth factor beta receptor 2 
TGF-β    Transforming growth factor beta 
Timm8b   Translocase of inner mitochondrial membrane 8 homolog b 
Timp1    Tissue inhibitor of metalloproteinase 1 
Tmem14c   Transmembrane proteome 14c 
Tnc    Tenascin c 
TNF    Tumor necrosis factor 
Tomm7   Translocase of outer mitochondrial membrane 7 
UBB    Ubiquitin B 
Uqcrc2   Ubiquinol-cytochrome c reductase core protein 2 
Vdac1    Voltage dependent anion channel 1 
Vdac3    Voltage dependent anion channel 3 
Vegfa    Vascular endothelial growth factor alpha 
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